Unnamed: 0.1,Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
52000,52000,,,19051596,[],CHEMBL4354971,Antibacterial activity against Escherichia coli by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178410,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,0.06
52001,52001,,,19051614,[],CHEMBL4354973,Antibacterial activity against Klebsiella by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178410,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC90,mg/L,UO_0000274,,0.12
52002,52002,,,19051628,[],CHEMBL4354974,Antibacterial activity against Bacteroides fragilis by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178410,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,mg/L,UO_0000274,,1.0
52003,52003,,,19051642,[],CHEMBL4354975,Antibacterial activity against Haemophilus influenzae with horse blood by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178410,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,mg/L,UO_0000274,,0.06
52004,52004,,,19051656,[],CHEMBL4354976,Antibacterial activity against Staphylococcus aureus by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178410,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,0.06
52005,52005,,,19051670,[],CHEMBL4354977,Antibacterial activity against Streptococcus pneumoniae by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178410,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,mg/L,UO_0000274,,0.12
52006,52006,,,19051684,[],CHEMBL4354978,Antibacterial activity against Streptococcus pyogenes by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178410,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,mg/L,UO_0000274,,0.25
52007,52007,,,19051698,[],CHEMBL4354979,Antibacterial activity against Enterococcus by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178410,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,mg/L,UO_0000274,,2.0
52008,52008,,,19051712,[],CHEMBL4354980,Antibacterial activity against Clostridium perfringens by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178410,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC90,mg/L,UO_0000274,,0.25
52009,52009,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,19051760,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'g', 'standard_value': '0.4', 'text_value': None, 'type': 'DOSE', 'units': 'g', 'value': '0.4'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL4355003,"Cmax in human at 0.4 g, po by HPLC analysis",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3178410,=,1,1,=,,Cmax,nM,,7722.2,CHEMBL612558,,ADMET,,,,Cmax,mg/L,UO_0000065,,3.1
52010,52010,,,19051761,[],CHEMBL4355004,"AUC in human at 0.4 g, po by HPLC analysis",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3178410,=,1,1,=,,AUC,ng.hr.mL-1,,30000.0,CHEMBL612558,,ADMET,,,,AUC,mg.hr/L,,,30.0
52011,52011,,,19051762,[],CHEMBL4355005,"Half life in human at 0.4 g, po by HPLC analysis",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,3178410,=,1,1,=,,T1/2,hr,,13.0,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,13.0
52012,52012,,,19051763,[],CHEMBL4355006,"Protein binding in human at 0.4 g, po by HPLC analysis",A,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3178410,=,1,1,=,,PPB,%,,50.0,CHEMBL612558,,ADMET,,,,PB,%,UO_0000187,,50.0
52013,52013,,,19073403,[],CHEMBL4362179,Antimycobacterial activity against Mycobacterium bovis BCG ATCC 35737 by resazurin dye based fluorimetric assay,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4359864,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,7.52,0,http://www.openphacts.org/units/Nanomolar,3182233,=,1,1,=,,IC50,nM,,30.0,CHEMBL615052,Mycobacterium tuberculosis variant bovis BCG,Mycobacterium tuberculosis variant bovis BCG,33892.0,,,IC50,uM,UO_0000065,,0.03
52014,52014,,,19073410,[],CHEMBL4362178,Antimycobacterial activity against Mycobacterium avium subsp. avium ATCC 25291 by resazurin dye based fluorimetric assay,F,,,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4359864,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,6.72,0,http://www.openphacts.org/units/Nanomolar,3182233,=,1,1,=,,IC50,nM,,190.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,0.19
52015,52015,,,19073419,[],CHEMBL4362177,Antimycobacterial activity against Mycobacterium marinum NCTC 2275 by resazurin dye based fluorimetric assay,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4359864,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,6.85,0,http://www.openphacts.org/units/Nanomolar,3182233,=,1,1,=,,IC50,nM,,140.0,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,,IC50,uM,UO_0000065,,0.14
52016,52016,,,19099299,[],CHEMBL4368178,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv incubated for 7 days by rapid direct susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4364323,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186255,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.12
52017,52017,,,19099317,[],CHEMBL4368179,Cytotoxicity against African green monkey Vero cells incubated for 72 hrs by MTT assay,A,,,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4364323,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186255,=,1,1,=,,CC50,ug.mL-1,,128.0,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,,CC50,ug ml-1,UO_0000274,,128.0
52018,52018,,,19099335,[],CHEMBL4368180,"Selectivity index, ratio of CC50 for African green monkey Vero cells to MIC for Mycobacterium tuberculosis H37Rv",T,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4364323,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3186255,=,1,0,=,,Selectivity Index,,,1024.0,CHEMBL612545,,Unchecked,,,,Selectivity Index,,,,1024.0
52019,52019,,,19099343,[],CHEMBL4368181,Inhibition of Mycobacterium tuberculosis DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4364323,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186255,=,1,1,=,,IC50,ug.mL-1,,5.5,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,IC50,ug ml-1,UO_0000274,,5.5
52020,52020,,,19099349,[],CHEMBL4368182,Antimycobacterial activity against rifampicin-resistant Mycobacterium tuberculosis incubated for 7 days by rapid direct susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4364323,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186255,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.5
52021,52021,,,19099357,[],CHEMBL4368183,Antimycobacterial activity against multidrug (isoniazid and rifampicin) resistant Mycobacterium tuberculosis 1 incubated for 7 days by rapid direct susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4364323,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186255,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
52022,52022,,,19099365,[],CHEMBL4368184,Antimycobacterial activity against multidrug (isoniazid and rifampicin) resistant Mycobacterium tuberculosis 2 incubated for 7 days by rapid direct susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4364323,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3186255,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.25
52023,52023,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,19099370,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL4368185,"Cmax in SPF ICR mouse at 100 mg/kg, sc",A,,,BAO_0002119,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4364323,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3186255,=,1,1,=,,Cmax,nM,,26853.33,CHEMBL612558,,ADMET,,,,Cmax,ng/ml,UO_0000065,,10783.0
52024,52024,,,19099373,[],CHEMBL4368186,"Half life in SPF ICR mouse at 100 mg/kg, sc",A,,,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4364323,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,3186255,=,1,1,=,,T1/2,hr,,2.6,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,2.6
52025,52025,,,19099376,[],CHEMBL4368187,"Tmax in SPF ICR mouse at 100 mg/kg, sc",A,,,BAO_0003037,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4364323,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Hour,3186255,=,1,1,=,,Tmax,hr,,0.45,CHEMBL612558,,ADMET,,,,Tmax,min,UO_0000032,,27.0
52026,52026,,,19099379,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '100.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/kg', 'value': '100.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SUBCUTANEOUS', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'SUBCUTANEOUS', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL4368188,"AUC (0 to infinity) in SPF ICR mouse at 100 mg/kg, sc",A,,,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4364323,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3186255,=,1,1,=,,AUC,ng.hr.mL-1,,19243.0,CHEMBL612558,,ADMET,,,,AUC,ng.hr/ml,,,19243.0
52027,52027,,,19166171,[],CHEMBL4384161,Antimycobacterial activity against Mycobacterium smegmatis CMCC 93202 after 72 hrs by double dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4382234,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198691,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,1.0,0.1
52028,52028,,,19166196,[],CHEMBL4384162,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 by rapid direct susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4382234,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198691,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,1.0,0.1
52029,52029,,,19166221,[],CHEMBL4384163,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 09710 by rapid direct susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4382234,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198691,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,1.0,0.1
52030,52030,,,19166248,[],CHEMBL4384164,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 3 to 7 days by rapid direct susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4382234,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198691,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.1
52031,52031,,,19166275,[],CHEMBL4384166,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis after 3 to 7 days by rapid direct susceptibility test,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4382234,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198691,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.12
52032,52032,,,19204731,[],CHEMBL4392088,Inhibition of Pks13 D1644G/N1640K double mutant thioesterase domain in Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth by microplate alamar blue assay,B,I6X8D2,"D1644G,N1640K",BAO_0000179,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4390673,J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3205373,=,1,0,=,,MIC=<90,ug ml-1,,0.0625,CHEMBL4105939,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),Polyketide synthase Pks13,83332.0,,,MIC=<90,ug ml-1,UO_0000274,0.125,0.0625
52033,52033,,,19237672,[],CHEMBL4399096,"Lipophilicity, log k of the compound at 100 ug/ml by micellar electrokinetic chromatography",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3211477,=,1,0,=,,log K,,,0.1083,CHEMBL2362975,,No relevant target,,,,log K,,,,0.1083
52034,52034,,,19237696,[],CHEMBL4399097,Antibacterial activity against Staphylococcus aureus ATCC 6538 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
52035,52035,,,19237719,[],CHEMBL4399098,Bactericidal activity against Staphylococcus aureus ATCC 6538 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.125
52036,52036,,,19237743,[],CHEMBL4399099,Antibacterial activity against methicillin resistant Staphylococcus aureus N315 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
52037,52037,,,19237766,[],CHEMBL4399100,Bactericidal activity against methicillin resistant Staphylococcus aureus N315 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.25
52038,52038,,,19237790,[],CHEMBL4399101,Antibacterial activity against Staphylococcus epidermidis ATCC 14990 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.063
52039,52039,,,19237813,[],CHEMBL4399102,Bactericidal activity against Staphylococcus epidermidis ATCC 14990 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC,ug ml-1,UO_0000274,,0.125
52040,52040,,,19237837,[],CHEMBL4399103,Antibacterial activity against Enterococcus hirae ATCC 1052 cultured in BHI medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,,MIC,ug ml-1,UO_0000274,,16.0
52041,52041,,,19237848,[],CHEMBL4399104,Bactericidal activity against Enterococcus hirae ATCC 1052 cultured in BHI medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,32.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,,MBC,ug ml-1,UO_0000274,,32.0
52042,52042,,,19237872,[],CHEMBL4399105,Antibacterial activity against Bacillus subtilis ATCC 6633 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,,MIC,ug ml-1,UO_0000274,,0.032
52043,52043,,,19237895,[],CHEMBL4399106,Bactericidal activity against Bacillus subtilis ATCC 6633 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,0.032,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,,MBC,ug ml-1,UO_0000274,,0.032
52044,52044,,,19237919,[],CHEMBL4399107,Antibacterial activity against Escherichia coli ATCC 8739 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.125
52045,52045,,,19237942,[],CHEMBL4399108,Bactericidal activity against Escherichia coli ATCC 8739 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.25
52046,52046,,,19237966,[],CHEMBL4399109,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
52047,52047,,,19237989,[],CHEMBL4399110,Bactericidal activity against Pseudomonas aeruginosa ATCC 9027 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,16.0
52048,52048,,,19238013,[],CHEMBL4399111,Antibacterial activity against Proteus vulgaris NCTC 4635 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.004
52049,52049,,,19238037,[],CHEMBL4399112,Bactericidal activity against Proteus vulgaris NCTC 4635 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,0.008,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MBC,ug ml-1,UO_0000274,,0.008
52050,52050,,,19238061,[],CHEMBL4399113,Antibacterial activity against methicillin resistant Staphylococcus aureus 6347 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.063
52051,52051,,,19238084,[],CHEMBL4399114,Bactericidal activity against methicillin resistant Staphylococcus aureus 6347 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,0.063,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.063
52052,52052,,,19238108,[],CHEMBL4399115,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 13199 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.032
52053,52053,,,19238131,[],CHEMBL4399116,Bactericidal activity against methicillin resistant Staphylococcus epidermidis ATCC 13199 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,0.032,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC,ug ml-1,UO_0000274,,0.032
52054,52054,,,19238155,[],CHEMBL4399117,Antibacterial activity against Streptococcus pneumoniae cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
52055,52055,,,19238169,[],CHEMBL4399118,Bactericidal activity against Streptococcus pneumoniae cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,,64.0
52056,52056,,,19238193,[],CHEMBL4399119,Antibacterial activity against Serratia marcescens ATCC 12795 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.25
52057,52057,,,19238216,[],CHEMBL4399120,Bactericidal activity against Serratia marcescens ATCC 12795 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211477,=,1,0,=,,MBC,ug ml-1,,0.5,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MBC,ug ml-1,UO_0000274,,0.5
52058,52058,,,19247101,[],CHEMBL4400925,Antibacterial activity against Streptococcus pyogenes CMCC 32067 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,>,1,1,>,,MIC,nM,,319200.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,umol/L,UO_0000065,,319.2
52059,52059,,,19247142,[],CHEMBL4400924,Antibacterial activity against Staphylococcus aureus CMCC 25923 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,310.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/L,UO_0000065,,0.31
52060,52060,,,19247183,[],CHEMBL4400923,Antibacterial activity against Staphylococcus aureus CMCC(B) 26003 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,310.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/L,UO_0000065,,0.31
52061,52061,,,19247228,[],CHEMBL4400928,Antibacterial activity against Bacillus subtilis CMCC 63501 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,4990.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,umol/L,UO_0000065,,4.99
52062,52062,,,19247270,[],CHEMBL4400927,Antibacterial activity against Enterococcus faecalis CMCC 29212 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,2490.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,umol/L,UO_0000065,,2.49
52063,52063,,,19247311,[],CHEMBL4400926,Antibacterial activity against Streptococcus pneumoniae CMCC 31968 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,>,1,1,>,,MIC,nM,,319200.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,umol/L,UO_0000065,,319.2
52064,52064,,,19247353,[],CHEMBL4400929,Antibacterial activity against Escherichia coli CMCC 25922 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,310.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/L,UO_0000065,,0.31
52065,52065,,,19247394,[],CHEMBL4400930,Antibacterial activity against Escherichia coli CMCC 44568 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,310.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/L,UO_0000065,,0.31
52066,52066,,,19247435,[],CHEMBL4400931,Antibacterial activity against Pseudomonas aeruginosa CMCC 27853 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,4990.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/L,UO_0000065,,4.99
52067,52067,,,19247476,[],CHEMBL4400932,Antibacterial activity against Pseudomonas aeruginosa CMCC 10104 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,9980.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/L,UO_0000065,,9.98
52068,52068,,,19247487,[],CHEMBL4400933,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,1250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/L,UO_0000065,,1.25
52069,52069,,,19247498,[],CHEMBL4400934,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,620.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/L,UO_0000065,,0.62
52070,52070,,,19247509,[],CHEMBL4400935,Antibacterial activity against multidrug-resistant Escherichia coli ATCC BAA-196 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,1250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/L,UO_0000065,,1.25
52071,52071,,,19247520,[],CHEMBL4400936,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa ATCC BAA-2111 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3213107,=,1,1,=,,MIC,nM,,2490.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/L,UO_0000065,,2.49
52072,52072,,,19252917,[],CHEMBL4402015,Antibacterial activity against drug-resistant Mycobacterium tuberculosis isolate 1 after 7 days by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400559,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3214377,=,1,1,=,,MIC,nM,,300.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.3
52073,52073,,,19252925,[],CHEMBL4402016,Antibacterial activity against drug-resistant Mycobacterium tuberculosis isolate 2 after 7 days by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400559,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3214377,=,1,1,=,,MIC,nM,,700.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.7
52074,52074,,,19252933,[],CHEMBL4402017,Antibacterial activity against drug-resistant Mycobacterium tuberculosis isolate 3 after 7 days by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400559,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3214377,=,1,1,=,,MIC,nM,,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.5
52075,52075,,,19252941,[],CHEMBL4402018,Antibacterial activity against drug-resistant Mycobacterium tuberculosis isolate 4 after 7 days by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400559,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3214377,=,1,1,=,,MIC,nM,,1400.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.4
52076,52076,,,19252949,[],CHEMBL4402019,Antibacterial activity against drug-resistant Mycobacterium tuberculosis isolate 5 after 7 days by resazurin microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400559,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3214377,=,1,1,=,,MIC,nM,,400.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.4
52077,52077,,,19252960,[],CHEMBL4402010,Antibacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4400559,Bioorg Med Chem Lett,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3214377,<,1,1,<,,MIC90,nM,,200.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.2
52078,52078,,,19260932,[],CHEMBL4404080,"Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in C57BL/6 mouse model of acute infection assessed as reduction in mycobacterial burden in lung at 100 mg/kg, po treated for 8 consecutive days starting from day 1 post-infection and measured after 24 hrs post-last dose (Rvb = 5.8 log10cfu)",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4402556,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3216078,=,1,0,=,,Activity,log10CFU,,2.7,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log10CFU,,,2.7
52079,52079,,,19265106,[],CHEMBL4405023,"In vivo antibacterial activity against Staphylococcus aureus ATCC 29213 infected in C57BL/6 mouse assessed as reduction in bacterial burden by measuring log10 CFU/cornea at 0.3% administered topically as two times on day 1, four times on day 2 and two times on day 3 measured at 48 hrs post-final dose by 10 fold serial dilution method (Rvb = 6.5 +/- 0.7 log10CFU)",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4402583,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3217037,=,1,0,=,,Activity,log10CFU,,3.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU,,,3.7
52080,52080,,,19271272,[],CHEMBL4406711,"Antimycobacterial activity against Mycobacterium tuberculosis H37Rv infected in C57BL/6J mouse assessed as reduction in bacterial burden in lung at 100 mg/kg, po administered once daily for 4 consecutive days starting from 5 days post infection and measured after 24 hrs post dose (Rvb = 7.4 +/- 0.1 log10CFU)",F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4402609,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3217919,=,1,0,=,,Activity,log10CFU,,3.3,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log10CFU,,,3.3
52081,52081,,Not Active,19287617,[],CHEMBL4410321,Antibacterial activity against mid-exponential growth phase of methicillin-resistant Staphylococcus aureus ATCC 700699 assessed as increase in cell lysis at 25 uM,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4406882,Bioorg Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3220585,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
52082,52082,,Not Active,19287619,[],CHEMBL4410322,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 700699 assessed as reduction in bacterial CFU at 4 times MIC measured for 30 mins,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4406882,Bioorg Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3220585,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
52083,52083,,Not Active,19287633,[],CHEMBL4410337,Induction of membrane integrity impairment in methicillin-resistant Staphylococcus aureus ATCC 700699 at 10 uM measured for 3 hrs by PI staining based fluorescence assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4406882,Bioorg Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3220585,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
52084,52084,,Not Active,19287636,[],CHEMBL4410339,Induction of membrane integrity impairment in methicillin-resistant Staphylococcus aureus ATCC 700699 at 20 uM measured for 30 mins by DiOC2(3) probe based fluorescence assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4406882,Bioorg Med Chem,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3220585,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
52085,52085,,,19406600,[],CHEMBL4426574,Bactericidal activity against methicillin-sensitive Staphylococcus aureus 29213 infected in mouse macrophages assessed as induction of bacterial kill at 4 ug/ml in presence of 4 ug/ml rifampin after 24 hrs,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4425125,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3243528,<=,1,0,<=,,Activity,%,,99.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,99.9
52086,52086,,,19406602,[],CHEMBL4426575,Bactericidal activity against methicillin-resistant Staphylococcus aureus 29213 infected in mouse macrophages assessed as induction of bacterial kill at 4 ug/ml in presence of 4 ug/ml rifampin after 24 hrs,F,,,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4425125,J Med Chem,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3243528,<=,1,0,<=,,Activity,%,,99.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,99.9
52087,52087,,,19466549,[],CHEMBL4477860,Antibacterial activity against Staphylococcus aureus ATCC 700699 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4477198,J Nat Prod,2016.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3255180,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
52088,52088,,,19958081,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4495564,,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3344499,=,52,1,=,,Inhibition,%,,29.02,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,29.02
52089,52089,,,20152284,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4495565,,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3362371,=,52,1,=,,Inhibition,%,,-0.07,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.07
52090,52090,,,20640489,[],CHEMBL4612952,Induction of Escherichia coli K12 MG1655 recA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,,,BAO_0000179,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4610120,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3473711,=,1,0,=,,FC,,,20.0,CHEMBL3434,Escherichia coli K-12,Recombinase A,83333.0,,,FC,,,35.0,20.0
52091,52091,,,20640496,[],CHEMBL4612953,Induction of Escherichia coli K12 MG1655 lexA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,,,BAO_0000179,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4610120,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3473711,=,1,0,=,,FC,,,5.0,CHEMBL4630871,Escherichia coli,LexA repressor,562.0,,,FC,,,13.0,5.0
52092,52092,,,20640503,[],CHEMBL4612954,Induction of Escherichia coli K12 MG1655 recN promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,,,BAO_0000179,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4610120,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3473711,=,1,0,=,,FC,,,14.0,CHEMBL4630870,Escherichia coli,DNA repair protein RecN,562.0,,,FC,,,32.0,14.0
52093,52093,,,20640510,[],CHEMBL4612955,Induction of Escherichia coli K12 MG1655 sulA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,,,BAO_0000179,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4610120,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3473711,=,1,0,=,,FC,,,17.0,CHEMBL1287594,Escherichia coli K-12,Cell division inhibitor sulA,83333.0,,,FC,,,41.0,17.0
52094,52094,,Not Active,20650424,[],CHEMBL4615535,Bacteriostatic activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth at 0.07 ug/ml incubated for 3 to 4 weeks by time kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4613277,ACS Med Chem Lett,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3476057,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
52095,52095,,Active,20650425,[],CHEMBL4615536,Bactericidal activity against Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth at 0.35 ug/ml incubated for 3 to 4 weeks by time kill assay,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4613277,ACS Med Chem Lett,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3476057,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
52096,52096,,Active,20650428,[],CHEMBL4615537,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv infected in mouse J774.1 cells assessed as reduction in bacterial colony at 1 to 10 times MIC incubated for 72 hrs by colony counting method,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4613277,ACS Med Chem Lett,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3476057,,1,0,,,Inhibition,%,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,INH,,UO_0000187,,
52097,52097,,,20692069,[],CHEMBL4625799,Antimalarial activity against CQ-sensitive Plasmodium falciparum 3D7 assessed as inhibition of parasite growth,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4622966,ACS Med Chem Lett,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3485176,>,1,1,>,,IC50,nM,,10000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,10.0
52098,52098,,,20692070,[],CHEMBL4625800,Antimalarial activity against CQ-resistant Plasmodium falciparum NF54-R assessed as inhibition of parasite growth,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4622966,ACS Med Chem Lett,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3485176,>,1,1,>,,IC50,nM,,10000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,10.0
52099,52099,,,22073861,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4495565,,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3362371,=,52,1,=,,Inhibition,%,,-0.07,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.07
52100,52100,,No. Measurements = 1,22084368,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4651402,,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3493374,>,57,1,>,,IC50,nM,,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,IC50,M,UO_0000065,,2e-05
52101,52101,,No. Measurements = 1,22084369,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4651402,,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3493374,<,57,1,>,,IC50,nM,,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,pIC50,,UO_0000065,,4.7
52102,52102,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408648,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671004,Binding affinity to Zinc ion assessed as performance ratio ratio by measuring product of accounting ratio and retention ratio at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,1.05,CHEMBL2362975,,No relevant target,,,,Ratio,,,,1.05
52103,52103,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408665,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671005,Binding affinity to Nickel cation assessed as performance ratio ratio by measuring product of accounting ratio and retention ratio at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,0.89,CHEMBL2362975,,No relevant target,,,,Ratio,,,,0.89
52104,52104,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408682,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671006,Binding affinity to Nickel cation assessed as retention ratio by measuring compound detected in elution fraction/total compound detected at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,1.0,CHEMBL2362975,,No relevant target,,,,Ratio,,,,1.0
52105,52105,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408699,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671007,Binding affinity to Nickel cation assessed as accounting ratio by measuring total compound detected/total compound adsorbed at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,0.89,CHEMBL2362975,,No relevant target,,,,Ratio,,,,0.89
52106,52106,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408716,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671008,Binding affinity to Gallium ion assessed as performance ratio ratio by measuring product of accounting ratio and retention ratio at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,0.02,CHEMBL2362975,,No relevant target,,,,Ratio,,,,0.02
52107,52107,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408733,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671009,Binding affinity to Gallium ion assessed as retention ratio by measuring compound detected in elution fraction/total compound detected at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,0.14,CHEMBL2362975,,No relevant target,,,,Ratio,,,,0.14
52108,52108,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408750,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671010,Binding affinity to gallium ion assessed as accounting ratio by measuring total compound detected/total compound adsorbed at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,0.16,CHEMBL2362975,,No relevant target,,,,Ratio,,,,0.16
52109,52109,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408767,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671011,Binding affinity to Ferric ion assessed as performance ratio ratio by measuring product of accounting ratio and retention ratio at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,0.15,CHEMBL2362975,,No relevant target,,,,Ratio,,,,0.15
52110,52110,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408784,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671012,Binding affinity to Ferric ion assessed as retention ratio by measuring compound detected in elution fraction/total compound detected at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,0.73,CHEMBL2362975,,No relevant target,,,,Ratio,,,,0.73
52111,52111,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408801,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671013,Binding affinity to cupric ion assessed as performance ratio ratio by measuring product of accounting ratio and retention ratio at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,0.24,CHEMBL2362975,,No relevant target,,,,Ratio,,,,0.24
52112,52112,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408818,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671014,Binding affinity to cupric ion assessed as retention ratio by measuring compound detected in elution fraction/total compound detected at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,0.95,CHEMBL2362975,,No relevant target,,,,Ratio,,,,0.95
52113,52113,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408835,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671015,Binding affinity to cupric ion assessed as accounting ratio by measuring total compound detected/total compound adsorbed at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,0.25,CHEMBL2362975,,No relevant target,,,,Ratio,,,,0.25
52114,52114,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408852,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671016,Binding affinity to zinc ion assessed as accounting ratio by measuring total compound detected/total compound adsorbed at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,1.05,CHEMBL2362975,,No relevant target,,,,Ratio,,,,1.05
52115,52115,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408869,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671017,Binding affinity to Zinc ion assessed as retention ratio by measuring compound detected in elution fraction/total compound detected at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,1.0,CHEMBL2362975,,No relevant target,,,,Ratio,,,,1.0
52116,52116,"{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'}",,22408886,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'micromol', 'standard_value': '2.55', 'text_value': None, 'type': 'Dose', 'units': 'micromol', 'value': '2.55'}]",CHEMBL4671018,Binding affinity to ferric ion assessed as accounting ratio by measuring total compound detected/total compound adsorbed at 2.55 umol by immobilized metal-ion affinity chromatography,B,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4665817,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3511112,=,1,0,=,,Ratio,,,0.21,CHEMBL2362975,,No relevant target,,,,Ratio,,,,0.21
52117,52117,,,22448571,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4680395,Potentiation of conjugate 10-induced antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as conjugate 10 MIC measured after 18 hrs by CLSI protocol based microbroth dilution method (Rvb = 64 to 128 ug/ml),F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4680060,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518429,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
52118,52118,,,22448574,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4680396,Potentiation of conjugate 11-induced antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as conjugate 11 MIC measured after 18 hrs by CLSI protocol based microbroth dilution method (Rvb = 64 to 128 ug/ml),F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4680060,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518429,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
52119,52119,,,22448577,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4680397,Potentiation of conjugate 12-induced antibacterial activity against wild type Pseudomonas aeruginosa PAO1 assessed as conjugate 12 MIC measured after 18 hrs by CLSI protocol based microbroth dilution method (Rvb = 64 to 128 ug/ml),F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4680060,Medchemcomm,2019.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3518429,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
52120,52120,,,22462096,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microg/ml', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microg/ml', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4683209,Antimycobacterial activity against dormant form of Mycobacterium tuberculosis H37Rv assessed as log fold reduction in bacterial count at 10 ug/ml under nutrient starvation condition after 7 days by MPN assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4680141,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3520352,=,1,0,=,,FC,,,1.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,FC,,,,1.5
52121,52121,,,22475083,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '840.0', 'text_value': None, 'type': 'Time', 'units': 'weeks', 'value': '5.0'}]",CHEMBL4686038,Antitubercular activity against 6-weeks nutrient starved phase cultures of Mycobacterium tuberculosis H37Rv assessed as log reduction in bacterial growth at 10 uM treated for 7 days measured after 4 weeks relative to control,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4680225,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3522538,=,1,0,=,,log(activity),,,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log(activity),,,,2.0
52122,52122,,,22475091,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'weeks', 'value': '1.0'}]",CHEMBL4686039,Antibiofilm activity against Mycobacterium tuberculosis assessed as log reduction in bacterial growth at 10 uM measured after 1 week relative to control,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4680225,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3522538,=,1,0,=,,log(activity),,,1.8,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,log(activity),,,,1.8
52123,52123,,Not Active,22770653,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL4704375,Induction of cell membrane permeabilization in methicillin resistant Staphylococcus aureus ATCC 700699 measured at 5 mins interval for 2 hrs by propidium iodide staining based fluorescence assay,B,,,BAO_0000375,BAO_0000220,subcellular format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4699592,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3535135,,1,0,,,Activity,,,,CHEMBL2364031,Bacteria,Cell membrane,2.0,,,Activity,,,,
52124,52124,,Not Active,22770656,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '0.5'}]",CHEMBL4704376,Induction of cell membrane permeabilization in GFP-expressing Staphylococcus aureus ATCC 700699 assessed as increase in cellular ATP leakage at 5 fold MIC measured after 0.5 hrs by Bactiter-glo assay,B,,,BAO_0000375,BAO_0000220,subcellular format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4699592,J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3535135,,1,0,,,Activity,,,,CHEMBL2364031,Bacteria,Cell membrane,2.0,,,Activity,,,,
52125,52125,,,22790240,[],CHEMBL4709365,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4706534,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3538761,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
52126,52126,,,22891082,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'Dose', 'units': 'mg', 'value': '400.0'}]",CHEMBL4729405,Oral bioavailability in human at 400 mg measured every 12 hrs,A,,,BAO_0003042,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3552648,=,1,1,=,,F,%,,92.0,CHEMBL612558,,ADMET,,,,F,%,UO_0000187,,92.0
52127,52127,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22891086,[],CHEMBL4729407,Inhibition of human ERG by whole-cell patch clamp method,B,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4725368,Bioorg Med Chem Lett,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Micromolar,3552648,=,1,0,=,,INH,uM,,129.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,INH,uM,UO_0000064,,129.0
52128,52128,,,22975754,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771719,Antimicrobial activity against Escherichia coli NCTC 11954 producing penicillinase assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,<,1,1,<,,MIC,nM,,500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.0005
52129,52129,,,22975761,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771720,Antimicrobial activity against Escherichia coli ATCC 8739 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,<,1,1,<,,MIC,nM,,500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.0005
52130,52130,,,22975774,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771721,Antimicrobial activity against Escherichia coli O157:H7 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,<,1,1,<,,MIC,nM,,500.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.0005
52131,52131,,,22975783,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771722,Antimicrobial activity against fluoroquinolone-resistant Escherichia coli assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,=,1,1,=,,MIC,nM,,3400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.0034
52132,52132,,,22975791,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771723,Antimicrobial activity against Salmonella enterica ATCC 13312 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,<,1,1,<,,MIC,nM,,4300.0,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,,MIC,mM,UO_0000065,,0.0043
52133,52133,,,22975798,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771724,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9627 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,=,1,1,=,,MIC,nM,,71500.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.0715
52134,52134,,,22975808,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771725,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,<,1,1,<,,MIC,nM,,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.0005
52135,52135,,,22975815,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771726,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus ATCC 9253 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,<,1,1,<,,MIC,nM,,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.0005
52136,52136,,,22975824,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771727,Antimicrobial activity against Listeria monocytogenes ATCC 19115 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,<,1,1,<,,MIC,nM,,500.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,mM,UO_0000065,,0.0005
52137,52137,,,22975835,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4771728,Antifungal activity against Candida albicans ATCC 10231 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,=,1,1,=,,MIC,nM,,1100.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,mM,UO_0000065,,0.0011
52138,52138,,,22975846,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4771729,Antifungal activity against Aspergillus flavus ATCC 9643 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,=,1,1,=,,MIC,nM,,285500.0,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,,MIC,mM,UO_0000065,,0.2855
52139,52139,,,22975857,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4771730,Antifungal activity against Fusarium solani ATCC 36031 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,=,1,1,=,,MIC,nM,,285500.0,CHEMBL612506,Fusarium solani,Fusarium solani,169388.0,,,MIC,mM,UO_0000065,,0.2855
52140,52140,,,22975867,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4771731,Antifungal activity against Stachybotrys chartarum IBT 7711 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,=,1,1,=,,MIC,nM,,2300.0,CHEMBL613284,Stachybotrys chartarum,Stachybotrys chartarum,74722.0,,,MIC,mM,UO_0000065,,0.0023
52141,52141,,,22975877,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4771732,Antifungal activity against Penicillium chrysogenum ATCC 10106 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3567998,=,1,1,=,,MIC,nM,,1100.0,CHEMBL612847,Penicillium chrysogenum,Penicillium chrysogenum,5076.0,,,MIC,mM,UO_0000065,,0.0011
52142,52142,,,22975887,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771733,Cytotoxicity against rat L6 cells assessed as inhibition of cell viability incubated for 24 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,5.24,0,http://www.openphacts.org/units/Nanomolar,3567998,=,1,1,=,,IC50,nM,,5778.3,CHEMBL614793,Rattus norvegicus,L6,10116.0,,,IC50,uM,UO_0000065,,5.7783
52143,52143,,,22988828,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774839,Antitubercular activity against Mycobacterium tuberculosis H37Rv measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3570386,=,1,1,=,,MIC90,nM,,770.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,0.77
52144,52144,,,22988931,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL4774852,Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in human macrophages assessed as intracellular bacterial load at 0.5 MIC measured after 6 days (Rvb = 5.57 to 6.43 logCFU/ml),F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3570386,=,1,0,=,,Activity,log10CFU/ml,,4.02,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log10CFU/ml,,,4.02
52145,52145,,,22988936,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL4774853,Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in human macrophages assessed as intracellular bacterial load at MIC measured after 6 days (Rvb = 5.57 to 6.43 logCFU/ml),F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3570386,=,1,0,=,,Activity,log10CFU/ml,,3.77,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log10CFU/ml,,,3.77
52146,52146,,,22988941,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL4774854,Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in human macrophages assessed as intracellular bacterial load at 2 times MIC measured after 6 days (Rvb = 5.57 to 6.43 logCFU/ml),F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3570386,=,1,0,=,,Activity,log10CFU/ml,,3.93,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log10CFU/ml,,,3.93
52147,52147,,,22988946,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '144.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '6.0'}]",CHEMBL4774855,Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in human macrophages assessed as intracellular bacterial load at 4 times MIC measured after 6 days (Rvb = 5.57 to 6.43 logCFU/ml),F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3570386,=,1,0,=,,Activity,log10CFU/ml,,2.54,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log10CFU/ml,,,2.54
52148,52148,,,22988952,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774856,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Ala-90-Val mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3570386,=,1,1,=,,MIC90,nM,,3080.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,3.08
52149,52149,,,22988959,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774857,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Asp-94-Gly mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3570386,=,1,1,=,,MIC90,nM,,3080.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,3.08
52150,52150,,,22988966,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774858,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Gly-88-Cys mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3570386,=,1,1,=,,MIC90,nM,,6160.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,6.16
52151,52151,,,22988973,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774859,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Ser-91-Pro mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3570386,=,1,1,=,,MIC90,nM,,6160.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,6.16
52152,52152,,,22988980,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774860,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Ala-90-Val/gyrB Glu-540-Val mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3570386,=,1,1,=,,MIC90,nM,,6160.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,6.16
52153,52153,,,22988987,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774861,Antitubercular activity against FQ resistant Mycobacterium tuberculosis H37Rv harboring gyrA Asp-94-Gly/gyrB Asp-500-Asn mutant measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3570386,=,1,1,=,,MIC90,nM,,6160.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,6.16
52154,52154,,,22988994,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL4774862,Antitubercular activity against Mycobacterium tuberculosis XDR measured after 7 days by resazurin microtiter assay,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4765453,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3570386,=,1,1,=,,MIC90,nM,,6160.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,uM,UO_0000065,,6.16
52155,52155,,,23133421,[],CHEMBL4808149,Enzymatic assay of human HDAC6 with commercial peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808148,,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3595249,=,59,1,=,,Inhibition,%,,12.48,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,12.48
52156,52156,,,23135414,[],CHEMBL4808150,Enzymatic assay of human HDAC6 with custom peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808148,,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3595249,=,59,1,=,,Inhibition,%,,-8.76,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,-8.76
52157,52157,,,23145681,[],CHEMBL4809357,Antibacterial activity against Fluoroquinolone-sensitive Staphylococcus aureus ATCC 49951 assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808184,J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3597537,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
52158,52158,,,23145735,[],CHEMBL4809358,Antibacterial activity against Fluoroquinolone-resistant Staphylococcus aureus ATCC 49951 assessed as reduction in bacterial growth by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808184,J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3597537,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
52159,52159,,,23145791,[],CHEMBL4809359,"Selectivity index, ratio of MIC for Fluoroquinolone-resistant Staphylococcus aureus ATCC 49951 to MIC for Fluoroquinolone-sensitive Staphylococcus aureus ATCC 49951",F,,,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808184,J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3597537,=,1,0,=,,Ratio,,,64.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,64.0
52160,52160,,,23145796,[],CHEMBL4809360,"Lipophilicity, logD of compound in octanol and water at pH 7.4 incubated overnight by LC/UV/qTOF method",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808184,J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3597537,=,1,1,=,,LogD,,,0.63,CHEMBL2362975,,No relevant target,,,,logD,,,,0.63
52161,52161,,,23145847,[],CHEMBL4809361,"Dissociation constant, pKa of the compound by UV metric method",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808184,J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3597537,=,1,0,=,,pKa,,,6.7,CHEMBL2362975,,No relevant target,,,,pKa,,,,6.7
52162,52162,,,23145886,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4809362,Cytotoxicity against human HepG2 cells after 72 hrs by CellTiter Glo assay,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808184,J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3597537,>,1,1,>,,EC50,nM,,100000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,EC50,uM,UO_0000065,,100.0
52163,52163,,,23145895,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL4809363,Cytotoxicity against human K562 cells after 72 hrs by CellTiter Glo assay,F,,,BAO_0000188,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808184,J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3597537,>,1,1,>,,EC50,nM,,100000.0,CHEMBL385,Homo sapiens,K562,9606.0,,,EC50,uM,UO_0000065,,100.0
52164,52164,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,23145934,[],CHEMBL4809367,Inhibition of human ERG expressed in CHO cells by whole cell patch-clamp method,B,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4808184,J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,1,http://www.openphacts.org/units/Nanomolar,3597537,=,1,1,=,,IC50,nM,,129000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,uM,UO_0000065,,129.0
52165,52165,,,23145958,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL4809370,Plasma protein binding in CD1 mouse at 10 uM after 4 hrs by LC-MS/MS analysis,A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808184,J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3597537,=,1,1,=,,PPB,%,,24.0,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,,24.0
52166,52166,,,23145968,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL4809371,Plasma protein binding in Sprague-Dawley rat at 10 uM after 4 hrs by LC-MS/MS analysis,A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808184,J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3597537,=,1,1,=,,PPB,%,,31.0,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,,31.0
52167,52167,,,23145978,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '10.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '10.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '4.0'}]",CHEMBL4809372,Plasma protein binding in human at 10 uM after 4 hrs by LC-MS/MS analysis,A,,,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4808184,J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3597537,=,1,1,=,,PPB,%,,19.0,CHEMBL612558,,ADMET,,,,PPB,%,UO_0000187,,19.0
52168,52168,,,23195634,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '17.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '17.0'}]",CHEMBL4819638,Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC2517 assessed as inhibition of bacterial growth measured after 17 hrs by resazurin based flourimetric assay,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL4818997,Eur J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,6.6,0,http://www.openphacts.org/units/Nanomolar,3607285,=,1,1,=,,IC50,nM,,250.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,IC50,uM,UO_0000065,,0.25
52169,52169,,,24393547,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5041706,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv clinical isolates 1 assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038652,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3779516,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.2
52170,52170,,,24393556,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5041709,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv infected in mouse J774.A1 cells assessed as log reduction of bacterial growth at 1X MIC measured after 3 days by visual colony counting analysis,F,,,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038652,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3779516,=,1,0,=,,Activity,log10CFU,,0.11,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,log10CFU,,,0.11
52171,52171,,,24393562,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5041710,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv clinical isolates 4 assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038652,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3779516,<,1,1,<,,MIC,ug.mL-1,,0.1,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.1
52172,52172,,,24393567,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5041711,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv clinical isolates 3 assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038652,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3779516,=,1,1,=,,MIC,ug.mL-1,,10.26,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,10.26
52173,52173,,,24393572,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5041712,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv clinical isolates 2 assessed as reduction in bacterial growth incubated for 7 days by resazurin dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038652,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3779516,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,0.19
52174,52174,,,24395623,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5042340,Antimycobacterial activity against Mycobacterium abscessus subsp. abscessus bamboo strain assessed as inhibition of mycobacterial growth incubated for 3 days by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038674,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3779997,=,1,1,=,,MIC90,nM,,2000.0,CHEMBL612545,,Unchecked,,,,MIC90,uM,UO_0000065,,2.0
52175,52175,,,24395651,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5042342,Antimycobacterial activity against Mycobacterium abscessus ATCC 19977 assessed as inhibition of mycobacterial growth incubated for 3 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038674,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3779997,=,1,1,=,,MIC90,nM,,2000.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC90,uM,UO_0000065,,2.0
52176,52176,,,24395656,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5042343,Antimycobacterial activity against Mycobacterium abscessus subsp. bolletii CCUG 50184T assessed as inhibition of mycobacterial growth incubated for 3 days by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038674,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3779997,=,1,1,=,,MIC90,nM,,4000.0,CHEMBL612545,,Unchecked,,,,MIC90,uM,UO_0000065,,4.0
52177,52177,,,24395661,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5042344,Antimycobacterial activity against Mycobacterium abscessus subsp. massiliense CCUG 48898T assessed as inhibition of mycobacterial growth incubated for 3 days by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038674,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3779997,=,1,1,=,,MIC90,nM,,4000.0,CHEMBL612545,,Unchecked,,,,MIC90,uM,UO_0000065,,4.0
52178,52178,,,24395666,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5042345,Antimycobacterial activity against Mycobacterium abscessus K21 assessed as inhibition of mycobacterial growth incubated for 3 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038674,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3779997,=,1,1,=,,MIC90,nM,,4000.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC90,uM,UO_0000065,,4.0
52179,52179,,,24395671,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5042346,Antimycobacterial activity against Mycobacterium avium 11 assessed as inhibition of mycobacterial growth incubated for 3 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038674,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3779997,=,1,1,=,,MIC90,nM,,600.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC90,uM,UO_0000065,,0.6
52180,52180,,,24395676,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '3.0'}]",CHEMBL5042347,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth incubated for 3 days by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5038674,ACS Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3779997,=,1,1,=,,MIC90,nM,,200.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,uM,UO_0000065,,0.2
52181,52181,,,24733433,[],CHEMBL5116261,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis assessed as mycobacterial growth inhibition,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5113423,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858162,=,1,1,=,,MIC50,ug.mL-1,,0.605,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,ug ml-1,UO_0000274,,0.605
52182,52182,,,24733439,[],CHEMBL5116261,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis assessed as mycobacterial growth inhibition,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5113423,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858162,=,1,1,=,,MIC90,ug.mL-1,,2.165,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,2.165
52183,52183,,,24733445,[],CHEMBL5116262,Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis assessed as mycobacterial growth inhibition,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5113423,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858162,=,1,1,=,,MIC50,ug.mL-1,,0.038,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,ug ml-1,UO_0000274,,0.038
52184,52184,,,24733451,[],CHEMBL5116262,Antimycobacterial activity against drug-sensitive Mycobacterium tuberculosis assessed as mycobacterial growth inhibition,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5113423,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858162,=,1,1,=,,MIC90,ug.mL-1,,0.071,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,0.071
52185,52185,,,24737356,[],CHEMBL5117270,Antimycobacterial activity against clinical isolate multidrug resistant Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5113463,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858900,=,1,1,=,,MIC50,ug.mL-1,,0.605,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,ug ml-1,UO_0000274,,0.605
52186,52186,,,24737357,[],CHEMBL5117270,Antimycobacterial activity against clinical isolate multidrug resistant Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5113463,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858900,=,1,1,=,,MIC90,ug.mL-1,,2.165,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,2.165
52187,52187,,,24737368,[],CHEMBL5117271,Antimycobacterial activity against clinical isolate drug susceptible Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5113463,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858900,=,1,1,=,,MIC50,ug.mL-1,,0.038,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,ug ml-1,UO_0000274,,0.038
52188,52188,,,24737369,[],CHEMBL5117271,Antimycobacterial activity against clinical isolate drug susceptible Mycobacterium tuberculosis H37Rv assessed as bacterial growth inhibition,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5113463,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3858900,=,1,1,=,,MIC90,ug.mL-1,,0.071,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,0.071
52189,52189,,,24759754,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5123421,Anti-tubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of mycobacterial growth incubated for 7 days by resazurin-dye based analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3863026,<=,1,1,<=,,MIC90,ug.mL-1,,0.07,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,0.07
52190,52190,,,24759773,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5123422,Cytotoxicity against mouse J774.A1 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin-dye based analysis,T,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3863026,=,1,1,=,,IC50,ug.mL-1,,14.56,CHEMBL614040,Mus musculus,J774.A1,10090.0,,,IC50,ug ml-1,UO_0000274,,14.56
52191,52191,,,24759788,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5123423,Cytotoxicity against human MRC5 cells assessed as reduction in cell viability incubated for 24 hrs by resazurin-dye based analysis,T,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3863026,>,1,1,>,,IC50,ug.mL-1,,100.0,CHEMBL614181,Homo sapiens,MRC5,9606.0,,,IC50,ug ml-1,UO_0000274,,100.0
52192,52192,,,24759803,[],CHEMBL5123424,"Selectivity index, ratio of IC50 for cytotoxicity against mouse J774.A1 cells to MIC90 for anti-tubercular activity against Mycobacterium tuberculosis H37Rv",T,,,BAO_0000179,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3863026,=,1,0,=,,Selectivity Index,,,208.96,CHEMBL612558,,ADMET,,,,Selectivity Index,,,,208.96
52193,52193,,,24759818,[],CHEMBL5123425,"Selectivity index, ratio of IC50 for cytotoxicity against human MRC5 cells to MIC90 for anti-tubercular activity against Mycobacterium tuberculosis H37Rv",T,,,BAO_0000179,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3863026,=,1,0,=,,Selectivity Index,,,1434.89,CHEMBL612558,,ADMET,,,,Selectivity Index,,,,1434.89
52194,52194,,,24759824,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5123426,Anti-tubercular activity against Mycobacterium tuberculosis CF16 assessed as inhibition of mycobacterial growth incubated for 7 days by resazurin-dye based analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3863026,=,1,1,=,,MIC90,ug.mL-1,,0.14,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,0.14
52195,52195,,,24759833,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5123427,Anti-tubercular activity against Mycobacterium tuberculosis CF61 assessed as inhibition of mycobacterial growth incubated for 7 days by resazurin-dye based analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3863026,=,1,1,=,,MIC90,ug.mL-1,,0.27,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,0.27
52196,52196,,,24759842,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5123428,Anti-tubercular activity against Mycobacterium tuberculosis CF76 assessed as inhibition of mycobacterial growth incubated for 7 days by resazurin-dye based analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3863026,=,1,1,=,,MIC90,ug.mL-1,,0.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,0.2
52197,52197,,,24759851,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5123429,Anti-tubercular activity against Mycobacterium tuberculosis CF152 assessed as inhibition of mycobacterial growth incubated for 7 days by resazurin-dye based analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3863026,=,1,1,=,,MIC90,ug.mL-1,,0.57,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,0.57
52198,52198,,,24759860,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5123430,Anti-tubercular activity against Mycobacterium tuberculosis CF161 assessed as inhibition of mycobacterial growth incubated for 7 days by resazurin-dye based analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3863026,=,1,1,=,,MIC90,ug.mL-1,,0.17,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC90,ug ml-1,UO_0000274,,0.17
52199,52199,,,24759869,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microg/ml', 'standard_value': '0.07', 'text_value': None, 'type': 'Dose', 'units': 'microg/ml', 'value': '0.07'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '288.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '12.0'}]",CHEMBL5123433,Anti-tubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth at 0.07 ug/ml incubated for 12 days by time-kill kinetics analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3863026,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
52200,52200,,Active,24759875,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5123434,Anti-tubercular activity against Mycobacterium tuberculosis infected in mouse J774.A1 cells assessed as inhibition of intracellular bacilli growth incubated for 72 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5120848,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3863026,,1,0,,,Activity,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,Activity,,,,
52201,52201,,,24774763,[],CHEMBL5127476,Antimycobacterial activity against Mycobacterium tuberculosis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5126519,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3866020,=,1,1,=,,MIC,nM,,1100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,1.1
52202,52202,,,24793182,[],CHEMBL5133093,Antibacterial activity against methicillin-resistant Staphylococcus aureus 197,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
52203,52203,,,24793194,[],CHEMBL5133094,Antibacterial activity against Acinetobacter baumannii ATCC 19606,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,0.25
52204,52204,,,24793206,[],CHEMBL5133095,Antibacterial activity against Acinetobacter baumannii 139,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,2.0
52205,52205,,,24793218,[],CHEMBL5133096,Antibacterial activity against Acinetobacter baumannii 140,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mg/L,UO_0000274,,4.0
52206,52206,,,24793230,[],CHEMBL5133097,Antibacterial activity against Escherichia coli ATCC 35218,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.06
52207,52207,,,24793242,[],CHEMBL5133098,Antibacterial activity against Escherichia coli 202,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,0.5
52208,52208,,,24793254,[],CHEMBL5133099,Antibacterial activity against Escherichia coli 203,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,8.0
52209,52209,,,24793266,[],CHEMBL5133100,Antibacterial activity against Neisseria gonorrhoeae ATCC 19424,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.06
52210,52210,,,24793278,[],CHEMBL5133101,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,1.0
52211,52211,,,24793290,[],CHEMBL5133102,Antibacterial activity against Pseudomonas aeruginosa 142,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,8.0
52212,52212,,,24793302,[],CHEMBL5133103,Antibacterial activity against Pseudomonas aeruginosa 143,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mg/L,UO_0000274,,16.0
52213,52213,,,24793314,[],CHEMBL5133104,Antibacterial activity against Streptococcus pneumoniae ATCC 49169,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.06
52214,52214,,,24793326,[],CHEMBL5133105,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.06
52215,52215,,,24793338,[],CHEMBL5133106,Antibacterial activity against methicillin-resistant Staphylococcus aureus 196,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
52216,52216,,,24793350,[],CHEMBL5133107,Antibacterial activity against Neisseria gonorrhoeae WHO K,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,2.0
52217,52217,,,24793354,[],CHEMBL5133108,Antibacterial activity against Neisseria gonorrhoeae WHO G,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.03
52218,52218,,,24793358,[],CHEMBL5133109,Antibacterial activity against Neisseria gonorrhoeae Barla194,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,16.0
52219,52219,,,24793362,[],CHEMBL5133110,Antibacterial activity against Neisseria gonorrhoeae WHO Q,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.016
52220,52220,,,24793366,[],CHEMBL5133111,Antibacterial activity against Neisseria gonorrhoeae WHO O,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.016
52221,52221,,,24793370,[],CHEMBL5133112,Antibacterial activity against Neisseria gonorrhoeae WHO M,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,2.0
52222,52222,,,24793374,[],CHEMBL5133113,Antibacterial activity against Neisseria gonorrhoeae WHO E,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.004
52223,52223,,,24793378,[],CHEMBL5133114,Antibacterial activity against Neisseria gonorrhoeae WHO C,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.016
52224,52224,,,24793382,[],CHEMBL5133115,Antibacterial activity against Neisseria gonorrhoeae WHO B,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.008
52225,52225,,,24793386,[],CHEMBL5133116,Antibacterial activity against Neisseria gonorrhoeae WHO A,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,0.004,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,0.004
52226,52226,,,24793390,[],CHEMBL5133117,Antibacterial activity against Neisseria gonorrhoeae WHO Z,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5131404,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3870238,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614430,Neisseria gonorrhoeae,Neisseria gonorrhoeae,485.0,,,MIC,mg/L,UO_0000274,,2.0
52227,52227,,,24837166,[],CHEMBL5144782,Antibacterial activity against rifampicin resistant Staphylococcus aureus harboring RpoBH481Y mutant assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879315,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.016
52228,52228,,,24837201,[],CHEMBL5144783,Antibacterial activity against wild type Staphylococcus aureus assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879315,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.016
52229,52229,,,24837236,[],CHEMBL5144784,Antibacterial activity against ciprofloxacin resistant Staphylococcus aureus harboring ParCS80F and GyrAS84L double mutant assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879315,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
52230,52230,,,24837271,[],CHEMBL5144785,Antibacterial activity against Staphylococcus aureus harboring RpoBH481Y/ParCS80F/GyrAS84L triple mutant assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879315,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
52231,52231,,,24837306,[],CHEMBL5144786,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143539,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879315,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.031
52232,52232,,,24846049,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146735,Antibacterial activity against methicillin resistant Staphylococcus aureus 032 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881066,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.12
52233,52233,,,24846064,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146736,"Antibacterial activity against beta-lactams, macrolide and fluoroquinolone resistant Streptococcus pneumoniae 718 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881066,=,1,1,=,,MIC,ug.mL-1,,3.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,3.12
52234,52234,,,24846070,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146737,Antibacterial activity against Staphylococcus aureus ATCC 25293 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881066,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
52235,52235,,,24846077,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146738,Antibacterial activity against methicillin resistant Staphylococcus aureus 5076 assessed as inhibition of bacterial growth incubated for 18 hrs by CLSI based serial agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881066,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,12.5
52236,52236,,,24846084,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5146739,Antibacterial activity against methicillin resistant Staphylococcus aureus 5076 harbouring DNA gyrase and topoisomerase IV mutant and efflux pump assessed as inhibition of bacterial growth incubated for 18 hrs in presence of efflux inhibitor by CLSI based serial agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881066,=,1,1,=,,MIC,ug.mL-1,,5.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,5.25
52237,52237,,,24846092,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'PO', 'standard_type': 'Route', 'standard_units': None, 'standard_value': None, 'text_value': 'PO', 'type': 'Route', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '168.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '7.0'}]",CHEMBL5146740,"Antibacterial activity against beta-lactams, macrolide and fluoroquinolone resistant Streptococcus pneumoniae 718 infected in po dosed Swiss mouse septicemia model assessed as protective dose administered on 1 and 5 hrs post infection and measured on day 7",F,,,BAO_0000188,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3881066,>,1,0,>,,EC50,mg kg-1,,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,EC50,mg kg-1,UO_0000308,,100.0
52238,52238,,,24846096,[],CHEMBL5146741,Induction of drug resistance in methicillin resistant Staphylococcus aureus assessed as increase in MIC measured after 10 passages (Rvb = 0.4 ug/ml),F,,,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5143624,Bioorg Med Chem Lett,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881066,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,6.25
52239,52239,,,24898298,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '192.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '8.0'}]",CHEMBL5159891,Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth measured after 8 days by Alamar blue assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154763,Eur J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3891383,=,1,1,=,,MIC,nM,,150.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.15
52240,52240,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24921767,[],CHEMBL5166518,Inhibition of Staphylococcus aureus ATTC 25923 DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,"{'bei': '12.87', 'le': '0.24', 'lle': '2.80', 'sei': '6.17'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,5.17,0,http://www.openphacts.org/units/Nanomolar,3895330,=,1,1,=,,IC50,nM,,6800.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,,IC50,uM,UO_0000065,,6.8
52241,52241,,,24921810,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '200.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '200.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '20.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5166519,Kinetic solubility of compound at 200 uM incubated for 20 hrs by shake flask method based HPLC-DAD analysis,P,,,BAO_0002135,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3895330,>,1,1,>,,Solubility,nM,,200000.0,CHEMBL2362975,,No relevant target,,,,Kinetic_solubility,uM,UO_0000065,,200.0
52242,52242,,,24921850,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '3.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '3.0'}]",CHEMBL5166520,"n-Octanol/phosphate buffer partition coefficient, logD of the compound at pH 7.4 incubated for 3 hrs by shake flask method based HPLC-DAD analysis",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3895330,=,1,1,=,,LogD,,,0.3,CHEMBL2362975,,No relevant target,,,,logD,,,,0.3
52243,52243,,,24921890,[],CHEMBL5166521,Cytotoxicity against human HepG2 cells assessed as reduction in cell viability by MTT assay,T,,,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3895330,>,1,1,>,,IC50,nM,,50000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,IC50,uM,UO_0000065,,50.0
52244,52244,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24921901,[],CHEMBL5166522,Inhibition of Mycobacterium tuberculosis H37Rv DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,"{'bei': '12.46', 'le': '0.24', 'lle': '2.63', 'sei': '5.97'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,5.0,1,http://www.openphacts.org/units/Nanomolar,3895330,=,1,1,=,,IC50,nM,,10000.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,,IC50,uM,UO_0000065,,10.0
52245,52245,,,24921943,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '192.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '8.0'}]",CHEMBL5166523,Antibacterial activity against Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth measured after 8 days by Alamar blue reagent based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3895330,=,1,1,=,,MIC,nM,,170.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,0.17
52246,52246,,,24921985,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '192.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '8.0'}]",CHEMBL5166524,Antibacterial activity against Staphylococcus aureus ATTC 25923 assessed as inhibition of bacterial growth measured after 8 days by Alamar blue reagent based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3895330,=,1,1,=,,MIC,nM,,140.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,0.14
52247,52247,,,24922027,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '192.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '8.0'}]",CHEMBL5166525,Antibacterial activity against Escherichia coli ATTC 25922 assessed as inhibition of bacterial growth measured after 8 days by Alamar blue reagent based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3895330,=,1,1,=,,MIC,nM,,140.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.14
52248,52248,,,24922038,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '264.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '11.0'}]",CHEMBL5166526,Antibacterial activity against wild type Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 11 days,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3895330,=,1,1,=,,MIC50,nM,,120.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,uM,UO_0000065,,0.12
52249,52249,,,24922041,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '264.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '11.0'}]",CHEMBL5166526,Antibacterial activity against wild type Mycobacterium tuberculosis H37Rv assessed as inhibition of bacterial growth incubated for 11 days,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Micromolar,3895330,=,1,0,=,,MIC99,uM,,0.19,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC99,uM,UO_0000064,,0.19
52250,52250,,,24922049,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '264.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '11.0'}]",CHEMBL5166527,Antibacterial activity against Mycobacterium tuberculosis H37Rv gyrA -FDASTetON-1 hypomorph assessed as inhibition of bacterial growth incubated for 11 days,F,,,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3895330,=,1,1,=,,MIC50,nM,,41.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,uM,UO_0000065,,0.0409999999999999
52251,52251,,,24922055,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '264.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '11.0'}]",CHEMBL5166527,Antibacterial activity against Mycobacterium tuberculosis H37Rv gyrA -FDASTetON-1 hypomorph assessed as inhibition of bacterial growth incubated for 11 days,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Micromolar,3895330,=,1,0,=,,MIC99,uM,,0.07,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC99,uM,UO_0000064,,0.07
52252,52252,,,24922063,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '264.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '11.0'}]",CHEMBL5166528,Selectivity ratio of MIC50 for wild type Mycobacterium tuberculosis H37Rv to MIC50 for Mycobacterium tuberculosis H37Rv gyrA -FDASTetON-1 hypomorph,F,,,BAO_0002136,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3895330,=,1,0,=,,Selectivity ratio,,,2.9,CHEMBL612545,,Unchecked,,,,Selectivity ratio,,,,2.9
52253,52253,,,24922070,[],CHEMBL5166529,Selectivity ratio of MIC99 for wild type Mycobacterium tuberculosis H37Rv to MIC99 for Mycobacterium tuberculosis H37Rv gyrA -FDASTetON-1 hypomorph,F,,,BAO_0002136,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3895330,=,1,0,=,,Selectivity ratio,,,2.5,CHEMBL612545,,Unchecked,,,,Selectivity ratio,,,,2.5
52254,52254,"{'action_type': 'STABILISER', 'description': 'Increases the conformational stability of a protein or complex', 'parent_type': 'OTHER'}",Active,24922074,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '100.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '30.0'}]",CHEMBL5166530,Stabilization of mycobacterium tuberculosis DNA gyrase/Doubly-cleaved DNA complex at 100 uM incubated for 30 mins by gel electrophoresis method,B,,,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5154899,J Med Chem,2022.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,,3895330,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
52255,52255,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25002715,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.3333', 'text_value': None, 'type': 'TIME', 'units': 'min', 'value': '20.0'}]",CHEMBL5233566,Inhibition of mushroom tyrosinase using L-DOPA as substrate incubated for 20 mins by microplate reader assay,B,,,BAO_0000190,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5233214,Eur J Med Chem,2020.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911621,=,1,1,=,,IC50,ug.mL-1,,1.2,CHEMBL3318,Agaricus bisporus,Tyrosinase,5341.0,,,IC50,ug ml-1,UO_0000274,,1.2
52256,52256,,,25029845,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5241305,Antimicrobial activity against Methicillin-resistant Staphylococcus aureus CCARM 3506 assessed as bacterial growth inhibition incubated for 24 hrs by ELISA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918668,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
52257,52257,,,25029982,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5241345,Antimicrobial activity against Methicillin sensitive Staphylococcus aureus assessed as bacterial growth inhibition incubated for 18 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5241058,Eur J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918668,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
52258,52258,,,25032671,[],CHEMBL5242331,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919804,<,1,1,<,,MIC,ug.mL-1,,0.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.6
52259,52259,,,25032716,[],CHEMBL5242332,Antibacterial activity against methicillin resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919804,<,1,1,<,,MIC,ug.mL-1,,0.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.6
52260,52260,,,25032746,[],CHEMBL5242333,Antibacterial activity against Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919804,<,1,1,<,,MIC,ug.mL-1,,0.6,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.6
52261,52261,,,25032769,[],CHEMBL5242334,Antibacterial activity against Listeria monocytogenes,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919804,<,1,1,<,,MIC,ug.mL-1,,0.6,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,ug ml-1,UO_0000274,,0.6
52262,52262,,,25032813,[],CHEMBL5242336,Antibacterial activity against Bacillus cereus,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919804,<,1,1,<,,MIC,ug.mL-1,,0.6,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.6
52263,52263,,,25040078,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5244529,Antimalarial activity against hepatic stage Plasmodium yoelii yoelii 265 BY for 48 hrs with media renew every 24 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922437,>,1,1,>,,IC50,ug.mL-1,,100.0,CHEMBL612328,Plasmodium yoelii yoelii,Plasmodium yoelii yoelii,73239.0,,,IC50,ug ml-1,UO_0000274,,100.0
52264,52264,,,25040102,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244530,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum NF54-R infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922437,=,1,1,=,,IC50,ug.mL-1,,18.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,18.0
52265,52265,,,25040128,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244531,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,,,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922437,=,1,1,=,,IC50,ug.mL-1,,44.8,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,44.8
52266,52266,,,25040732,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244793,Antimicrobial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs by Agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922739,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
52267,52267,,,25041061,[],CHEMBL5244842,Antibacterial activity against Escherichia coli TolC assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922886,=,1,1,=,,MIC,ug.mL-1,,11.54,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,11.54
52268,52268,,,25041307,[],CHEMBL5244890,Antibacterial activity against Escherichia coli H560 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922886,=,1,1,=,,MIC,ug.mL-1,,0.006,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.006
52269,52269,,,25041318,[],CHEMBL5244893,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922886,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,4.0
52270,52270,,,25041323,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5244894,Antibacterial activity against clinical isolate Escherichia coli assessed as bacterial growth inhibition incubated for 24 hrs by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922886,=,1,1,=,,MIC90,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,ug ml-1,UO_0000274,,32.0
52271,52271,,,25065676,[],CHEMBL5251416,Antibacterial activity against multi-drug resistant Acinetobacter baumannii assessed as bacterial growth inhibition by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5247650,J Med Chem,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3928734,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
52272,52272,,,25065682,[],CHEMBL5251417,Antibacterial activity against non multi-drug resistant Acinetobacter baumannii assessed as bacterial growth inhibition by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5247650,J Med Chem,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3928734,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,16.0
52273,52273,,,25065697,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'microg/ml', 'standard_value': '32.0', 'text_value': None, 'type': 'DOSE', 'units': 'microg/ml', 'value': '32.0'}]",CHEMBL5251425,Antibacterial activity against clinical isolate Acinetobacter baumannii assessed as bacterial growth inhibition at 32 ug/ml by CLSI based broth microdilution method relative to control,F,,,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5247650,J Med Chem,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://qudt.org/vocab/unit#Percent,3928734,=,1,1,=,,Inhibition,%,,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,INH,%,UO_0000187,,100.0
52274,52274,,,25103809,[],CHEMBL5262789,Antimycobacterial activity against Mycobacterium tuberculosis Rv0005 harbouring gyrB gene,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5260811,Eur J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936460,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,1.0
52275,52275,,,25103814,[],CHEMBL5262790,Antimycobacterial activity against Mycobacterium tuberculosis Rv0006 harbouring gyrA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5260811,Eur J Med Chem,2017.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3936460,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,ug ml-1,UO_0000274,,1.0
52276,52276,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25118860,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,4.6,0,http://www.openphacts.org/units/Nanomolar,3940740,=,1,1,=,,AC50,nM,,25000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,25.0
52277,52277,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120120,[],CHEMBL5291755,Compound was evaluated for inhibition of rat Cacna1c in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3762,Rattus norvegicus,Voltage-gated L-type calcium channel alpha-1C subunit,10116.0,,,AC50,uM,UO_0000065,,30.0
52278,52278,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25121242,[],CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,,AC50,uM,UO_0000065,,30.0
52279,52279,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25122447,[],CHEMBL5291740,Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52280,52280,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25123416,[],CHEMBL5291742,Binding affinity towards human ADRB2 in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52281,52281,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25124636,[],CHEMBL5291890,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
52282,52282,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25126753,[],CHEMBL5291770,Binding affinity towards human CHRNA4 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1882,Homo sapiens,Neuronal acetylcholine receptor protein alpha-4 subunit,9606.0,,,AC50,uM,UO_0000065,,30.0
52283,52283,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25128636,[],CHEMBL5291798,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,30.0
52284,52284,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25130059,[],CHEMBL5291853,"Binding affinity towards human OPRK1 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,"{'bei': '16.18', 'le': '0.31', 'lle': '4.12', 'sei': '7.75'}",CHEMBL32,MOXIFLOXACIN,CHEMBL32,6.5,0,http://www.openphacts.org/units/Nanomolar,3940740,=,1,1,=,,AC50,nM,,320.0,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,AC50,uM,UO_0000065,,0.32
52285,52285,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25131266,[],CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,30.0
52286,52286,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25132475,[],CHEMBL5291823,Binding affinity towards human HTR2C in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52287,52287,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25133665,[],CHEMBL5291724,Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52288,52288,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25134895,[],CHEMBL5291727,Binding affinity towards human ADORA3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52289,52289,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25136160,[],CHEMBL5291763,Compound was evaluated for inhibition of human CHRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,30.0
52290,52290,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25137358,[],CHEMBL5291767,Binding affinity towards human CHRM3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,=,1,1,=,,AC50,nM,,219998.6,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,AC50,uM,UO_0000065,,219.9986
52291,52291,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25138315,[],CHEMBL5291732,Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52292,52292,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25141026,[],CHEMBL5291781,"Binding affinity towards human DRD2 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52293,52293,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25142156,[],CHEMBL5291880,Binding affinity towards human SLC29A1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1997,Homo sapiens,Equilibrative nucleoside transporter 1,9606.0,,,AC50,uM,UO_0000065,,30.0
52294,52294,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25144378,[],CHEMBL5291737,Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52295,52295,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25145679,[],CHEMBL5291891,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
52296,52296,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25147329,[],CHEMBL5291854,Agonist activity at human OPRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52297,52297,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25148578,[],CHEMBL5291738,Compound was evaluated for inhibition of human ADRA2C in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52298,52298,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25149799,[],CHEMBL5291824,"Compound was evaluated for inhibition of human HTR3A in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1899,Homo sapiens,Serotonin 3a (5-HT3a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52299,52299,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25151004,[],CHEMBL5291892,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,30.0
52300,52300,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25153154,[],CHEMBL5291726,Binding affinity towards human ADORA2A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52301,52301,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25154750,[],CHEMBL5291852,Binding affinity towards human OPRD1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,=,1,1,=,,AC50,nM,,299999.1,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,AC50,uM,UO_0000065,,299.9991
52302,52302,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25155788,[],CHEMBL5291889,Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52303,52303,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25159034,[],CHEMBL5291878,Compound was evaluated for inhibition of human SCN5A in an in vitro cell-based assay measured by IonWorks automated patch clamp,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1980,Homo sapiens,Sodium channel protein type V alpha subunit,9606.0,,,AC50,uM,UO_0000065,,30.0
52304,52304,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25159151,[],CHEMBL5291756,Compound was evaluated for inhibition of human CACNA1C in an in vitro cell-based assay measured by IonWorks automated patch clamp,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1940,Homo sapiens,Voltage-gated L-type calcium channel alpha-1C subunit,9606.0,,,AC50,uM,UO_0000065,,30.0
52305,52305,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25160367,[],CHEMBL5291895,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,30.0
52306,52306,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25162775,[],CHEMBL5291750,Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52307,52307,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25163879,[],CHEMBL5291751,Binding affinity towards human AVPR2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1790,Homo sapiens,Vasopressin V2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52308,52308,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25166849,[],CHEMBL5291870,Compound was evaluated for inhibition of human PTGS2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,300000.0,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,AC50,uM,UO_0000065,,300.0
52309,52309,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25167891,[],CHEMBL5291791,Binding affinity towards human ESR1 in an in vitro cell free assay (NIBR assay) measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,30.0
52310,52310,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25169969,[],CHEMBL5291810,Agonist activity at human HRH2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52311,52311,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25171068,[],CHEMBL5291753,Binding affinity towards human BDKRB2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52312,52312,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25171929,[],CHEMBL5291758,Binding affinity towards human CCKBR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL298,Homo sapiens,Cholecystokinin B receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52313,52313,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25173413,[],CHEMBL5291803,Binding affinity towards human GHSR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4616,Homo sapiens,Ghrelin receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52314,52314,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25175070,[],CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,,AC50,uM,UO_0000065,,30.0
52315,52315,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25176460,[],CHEMBL5291850,"Binding affinity towards human NR3C1 in an in vitro cell free assay measured by filtration, radioactivity method",B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52316,52316,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25177650,[],CHEMBL5291744,Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL227,Homo sapiens,Type-1 angiotensin II receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52317,52317,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25178864,[],CHEMBL5291757,Binding affinity towards human CCKAR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52318,52318,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25179691,[],CHEMBL5291785,Binding affinity towards human EDNRA in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,300000.0,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,AC50,uM,UO_0000065,,300.0
52319,52319,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25181192,[],CHEMBL5291777,Agonist activity at human DRD1 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52320,52320,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25181994,[],CHEMBL5291773,Binding affinity towards human CNR1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52321,52321,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25184081,[],CHEMBL5291831,Binding affinity towards human MC3R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,AC50,uM,UO_0000065,,30.0
52322,52322,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25184781,[],CHEMBL5291832,Binding affinity towards human MC4R in an in vitro assay with cellular components measured by scintillation proximity assay in vitro assay with cellular components,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,AC50,uM,UO_0000065,,30.0
52323,52323,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25186028,[],CHEMBL5291858,Compound was evaluated for inhibition of human PDE4D in an in vitro cell free assay measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL288,Homo sapiens,Phosphodiesterase 4D,9606.0,,,AC50,uM,UO_0000065,,30.0
52324,52324,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187134,[],CHEMBL5291834,Binding affinity towards human NPY1R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,AC50,uM,UO_0000065,,30.0
52325,52325,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187811,[],CHEMBL5291748,Binding affinity towards rat Ar in an in vitro cell free assay measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,AC50,uM,UO_0000065,,30.0
52326,52326,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25188662,[],CHEMBL5291846,Binding affinity towards human NR1I2 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL3401,Homo sapiens,Pregnane X receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52327,52327,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25189842,[],CHEMBL5291833,Binding affinity towards human MLNR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL2203,Homo sapiens,Motilin receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52328,52328,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25191393,[],CHEMBL5291898,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
52329,52329,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25194209,[],CHEMBL5291899,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52330,52330,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25201145,[],CHEMBL5291921,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52331,52331,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25210789,[],CHEMBL5291920,Antagonist activity human CHRM1 in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,5.09,0,http://www.openphacts.org/units/Nanomolar,3940740,=,1,1,=,,AC50,nM,,8199.9,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,8.1999
52332,52332,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25211974,[],CHEMBL5291760,Agonist activity at human CHRM1 in an in vitro cell-based assay (NIBR assay) measured by Hamamatsu Functional Drug Screening System,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,300000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,300.0
52333,52333,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25213212,[],CHEMBL5291809,Binding affinity towards human HRH1 in an in vitro assay measured by filtration,B,,,BAO_0000186,BAO_0000357,single protein format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52334,52334,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25214405,[],CHEMBL5291765,Antagonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,30.0
52335,52335,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25215615,[],CHEMBL5291764,Agonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,30.0
52336,52336,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25216498,[],CHEMBL5291814,Antagonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52337,52337,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25217681,[],CHEMBL5291813,Agonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52338,52338,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25218575,[],CHEMBL5291901,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52339,52339,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25220552,[],CHEMBL5291735,Antagonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52340,52340,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25221758,[],CHEMBL5291734,Agonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52341,52341,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25222627,[],CHEMBL5291861,Antagonist activity at human PGR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52342,52342,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25223566,[],CHEMBL5291860,Agonist activity at human PGR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52343,52343,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25225811,[],CHEMBL5291817,Antagonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52344,52344,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25227005,[],CHEMBL5291816,Agonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52345,52345,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25228180,[],CHEMBL5291821,Antagonist activity at human HTR2B in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52346,52346,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25229385,[],CHEMBL5291819,Agonist activity at human HTR2B in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52347,52347,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25230365,[],CHEMBL5291729,Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52348,52348,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25231236,[],CHEMBL5291772,Antagonist activity at human CNR1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52349,52349,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25232137,[],CHEMBL5291771,Agonist activity at human CNR1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
52350,52350,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25234239,[],CHEMBL5291796,Agonist activity at human GABRA1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,300000.0,CHEMBL5303741,Homo sapiens,Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2,9606.0,,,AC50,uM,UO_0000065,,300.0
52351,52351,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25234539,[],CHEMBL5291797,Antagonist activity at human GABRA1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL32,MOXIFLOXACIN,CHEMBL32,,0,http://www.openphacts.org/units/Nanomolar,3940740,>,1,1,>,,AC50,nM,,300000.0,CHEMBL5303741,Homo sapiens,Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2,9606.0,,,AC50,uM,UO_0000065,,300.0
52352,52352,,Not Active,3473028,[],CHEMBL1266185,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,F,,,BAO_0000201,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1255231,Nat Chem Biol,2007.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://qudt.org/vocab/unit#Percent,958629,,1,0,,,Inhibition,%,,,CHEMBL612545,,Unchecked,,,,INH,,UO_0000187,,
52353,52353,,Inconclusive,3636695,[],CHEMBL1614544,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,4.7,0,http://www.openphacts.org/units/Nanomolar,980215,=,7,1,=,,Potency,nM,,19952.6,CHEMBL1293235,Homo sapiens,Prelamin-A/C,9606.0,,,Potency,um,UO_0000065,,19.9526
52354,52354,,Inconclusive,3649772,[],CHEMBL1614544,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,5.4,0,http://www.openphacts.org/units/Nanomolar,1252083,=,7,1,=,,Potency,nM,,3981.1,CHEMBL1293235,Homo sapiens,Prelamin-A/C,9606.0,,,Potency,um,UO_0000065,,3.9811
52355,52355,,Not Active,3930224,[],CHEMBL1614364,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000357,single protein format,Cl.NCCS,,,CHEMBL1201862,,,"{'bei': '80.36', 'le': '2.12', 'lle': '6.33', 'sei': '23.83'}",CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,6.2,0,http://www.openphacts.org/units/Nanomolar,1157591,=,7,1,=,,Potency,nM,,631.0,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,um,UO_0000065,,0.631
52356,52356,,Not Active,3935548,[],CHEMBL1614364,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000357,single protein format,Cl.NCCS,,,CHEMBL1201862,,,"{'bei': '80.36', 'le': '2.12', 'lle': '6.33', 'sei': '23.83'}",CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,6.2,0,http://www.openphacts.org/units/Nanomolar,980215,=,7,1,=,,Potency,nM,,631.0,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,um,UO_0000065,,0.631
52357,52357,,Not Active,3940876,[],CHEMBL1614364,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,B,,,BAO_0000186,BAO_0000357,single protein format,Cl.NCCS,,,CHEMBL1201862,,,"{'bei': '72.59', 'le': '1.91', 'lle': '5.73', 'sei': '21.52'}",CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,5.6,0,http://www.openphacts.org/units/Nanomolar,1252083,=,7,1,=,,Potency,nM,,2511.9,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,um,UO_0000065,,2.5119
52358,52358,,Inconclusive,3949335,[],CHEMBL1614502,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,4.95,0,http://www.openphacts.org/units/Nanomolar,1252083,=,7,1,=,,Potency,nM,,11220.2,CHEMBL1293224,Homo sapiens,Microtubule-associated protein tau,9606.0,,,Potency,um,UO_0000065,,11.2202
52359,52359,,Active,4010433,[],CHEMBL1614421,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",B,,,BAO_0000186,BAO_0000357,single protein format,Cl.NCCS,,,CHEMBL1201862,,,"{'bei': '63.51', 'le': '1.67', 'lle': '5.03', 'sei': '18.83'}",CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,4.9,0,http://www.openphacts.org/units/Nanomolar,980215,=,7,1,=,,Potency,nM,,12589.3,CHEMBL1293224,Homo sapiens,Microtubule-associated protein tau,9606.0,,,Potency,um,UO_0000065,,12.5893
52360,52360,,Active,4026885,[],CHEMBL1614421,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",B,,,BAO_0000186,BAO_0000357,single protein format,Cl.NCCS,,,CHEMBL1201862,,,"{'bei': '62.22', 'le': '1.64', 'lle': '4.93', 'sei': '18.45'}",CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,4.8,0,http://www.openphacts.org/units/Nanomolar,1252083,=,7,1,=,,Potency,nM,,15848.9,CHEMBL1293224,Homo sapiens,Microtubule-associated protein tau,9606.0,,,Potency,um,UO_0000065,,15.8489
52361,52361,,Active,4063008,[],CHEMBL1614421,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",B,,,BAO_0000186,BAO_0000357,single protein format,Cl.NCCS,,,CHEMBL1201862,,,"{'bei': '64.81', 'le': '1.71', 'lle': '5.13', 'sei': '19.22'}",CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,5.0,0,http://www.openphacts.org/units/Nanomolar,1157591,=,7,1,=,,Potency,nM,,10000.0,CHEMBL1293224,Homo sapiens,Microtubule-associated protein tau,9606.0,,,Potency,um,UO_0000065,,10.0
52362,52362,,Inconclusive,4168391,[],CHEMBL1614458,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,4.55,0,http://www.openphacts.org/units/Nanomolar,1157591,=,7,1,=,,Potency,nM,,28183.8,CHEMBL3577,Homo sapiens,Aldehyde dehydrogenase 1A1,9606.0,,,Potency,um,UO_0000065,,28.1838
52363,52363,,Inconclusive,4209960,[],CHEMBL1614459,PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,5.49,0,http://www.openphacts.org/units/Nanomolar,980215,=,7,1,=,,Potency,nM,,3264.3,CHEMBL612545,,Unchecked,,,,Potency,um,UO_0000065,,3.2643
52364,52364,,Active,4360911,[],CHEMBL1614174,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,4.3,0,http://www.openphacts.org/units/Nanomolar,980215,=,7,1,=,,Potency,nM,,50118.7,CHEMBL1293248,Bacillus subtilis,4'-phosphopantetheinyl transferase ffp,1423.0,,,Potency,um,UO_0000065,,50.1187
52365,52365,,Active,4383164,[],CHEMBL1614174,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,4.1,0,http://www.openphacts.org/units/Nanomolar,1252083,=,7,1,=,,Potency,nM,,79432.8,CHEMBL1293248,Bacillus subtilis,4'-phosphopantetheinyl transferase ffp,1423.0,,,Potency,um,UO_0000065,,79.4328
52366,52366,,Inconclusive,4513071,[],CHEMBL1614250,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,4.9,0,http://www.openphacts.org/units/Nanomolar,1252083,=,7,1,=,,Potency,nM,,12589.3,CHEMBL1293224,Homo sapiens,Microtubule-associated protein tau,9606.0,,,Potency,um,UO_0000065,,12.5893
52367,52367,,Inconclusive,4515156,[],CHEMBL1614250,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,4.9,0,http://www.openphacts.org/units/Nanomolar,980215,=,7,1,=,,Potency,nM,,12589.3,CHEMBL1293224,Homo sapiens,Microtubule-associated protein tau,9606.0,,,Potency,um,UO_0000065,,12.5893
52368,52368,,Inconclusive,4526418,[],CHEMBL1614250,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,5.55,0,http://www.openphacts.org/units/Nanomolar,1157591,=,7,1,=,,Potency,nM,,2818.4,CHEMBL1293224,Homo sapiens,Microtubule-associated protein tau,9606.0,,,Potency,um,UO_0000065,,2.8184
52369,52369,,Active,4612705,[],CHEMBL1614275,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,4.8,0,http://www.openphacts.org/units/Nanomolar,1157591,=,7,1,=,,Potency,nM,,15811.4,CHEMBL1293234,Giardia intestinalis,"Putative fructose-1,6-bisphosphate aldolase",5741.0,,,Potency,um,UO_0000065,,15.8114
52370,52370,,Inconclusive,4745957,[],CHEMBL1614522,"PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen)]",F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,8.8,0,http://www.openphacts.org/units/Nanomolar,1252083,=,7,1,=,,Potency,nM,,1.6,CHEMBL1293237,Homo sapiens,Bloom syndrome protein,9606.0,,,Potency,um,UO_0000065,,0.0016
52371,52371,,Inconclusive,4925793,[],CHEMBL1614067,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]",F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,8.8,0,http://www.openphacts.org/units/Nanomolar,1252083,=,7,1,=,,Potency,nM,,1.6,CHEMBL1293237,Homo sapiens,Bloom syndrome protein,9606.0,,,Potency,um,UO_0000065,,0.0016
52372,52372,,Active,5036057,[],CHEMBL1614080,PUBCHEM_BIOASSAY: Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics. (Class of assay: confirmatory) ,F,,,BAO_0002144,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,980215,>,7,1,>,,IC90,nM,,100000.0,CHEMBL612545,,Unchecked,,,,IC90,um,UO_0000065,,100.0
52373,52373,,inconclusive,5427882,[],CHEMBL1738184,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,980215,,7,1,,,Potency,nM,,6513.1,CHEMBL1075094,Homo sapiens,Nuclear factor erythroid 2-related factor 2,9606.0,,,Potency,uM,UO_0000065,,6.5131
52374,52374,,Active,5697403,[],CHEMBL1738442,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,980215,,7,1,,,Potency,nM,,44668.4,CHEMBL6032,Homo sapiens,"Histone-lysine N-methyltransferase, H3 lysine-9 specific 3",9606.0,,,Potency,uM,UO_0000065,,44.6684
52375,52375,,Active,5726608,[],CHEMBL1738442,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1252083,,7,1,,,Potency,nM,,44668.4,CHEMBL6032,Homo sapiens,"Histone-lysine N-methyltransferase, H3 lysine-9 specific 3",9606.0,,,Potency,uM,UO_0000065,,44.6684
52376,52376,,active,6426089,[],CHEMBL1794311,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,980215,,7,1,,,Potency,nM,,79432.8,CHEMBL1977,Homo sapiens,Vitamin D receptor,9606.0,,,Potency,uM,UO_0000065,,79.4328
52377,52377,,active,6431609,[],CHEMBL1794311,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1157591,,7,1,,,Potency,nM,,22387.2,CHEMBL1977,Homo sapiens,Vitamin D receptor,9606.0,,,Potency,uM,UO_0000065,,22.3872
52378,52378,,inconclusive,6438241,[],CHEMBL1794311,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1252083,,7,1,,,Potency,nM,,50118.7,CHEMBL1977,Homo sapiens,Vitamin D receptor,9606.0,,,Potency,uM,UO_0000065,,50.1187
52379,52379,,inconclusive,6646005,[],CHEMBL1794401,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,980215,,7,1,,,Potency,nM,,14125.4,CHEMBL1741193,Homo sapiens,Chromobox protein homolog 1,9606.0,,,Potency,uM,UO_0000065,,14.1254
52380,52380,,inconclusive,6756406,[],CHEMBL1794483,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,980215,,7,1,,,Potency,nM,,11220.2,CHEMBL5391,Homo sapiens,DNA polymerase iota,9606.0,,,Potency,uM,UO_0000065,,11.2202
52381,52381,,inactive,6817207,[],CHEMBL1794424,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1252083,,7,1,,,Potency,nM,,21192.3,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,,Potency,uM,UO_0000065,,21.1923
52382,52382,,inactive,6827399,[],CHEMBL1794424,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,980215,,7,1,,,Potency,nM,,79432.8,CHEMBL6035,Rattus norvegicus,"Thioredoxin reductase 1, cytoplasmic",10116.0,,,Potency,uM,UO_0000065,,79.4328
52383,52383,,active,7473402,[],CHEMBL1794375,"PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278]",B,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1252083,,7,1,,,Potency,nM,,11220.2,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,11.2202
52384,52384,,inactive,8282715,[],CHEMBL1963981,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614054,Homo sapiens,SN12C,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52385,52385,,inactive,8284345,[],CHEMBL1963976,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614078,Homo sapiens,MDA-N,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52386,52386,,inactive,8329709,[],CHEMBL1963985,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614997,Homo sapiens,NCI-H23,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52387,52387,,inactive,8399636,[],CHEMBL1963989,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614519,Homo sapiens,ACHN,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52388,52388,,inactive,8433058,[],CHEMBL1963990,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614388,Homo sapiens,UO-31,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52389,52389,,inactive,8499329,[],CHEMBL1963994,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL383,Homo sapiens,HL-60,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52390,52390,,inactive,8512791,[],CHEMBL1964018,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,45814.19,CHEMBL614860,Homo sapiens,SF-539,9606.0,,,log GI50 (M),,UO_0000065,,-4.339
52391,52391,,inactive,8550657,[],CHEMBL1964017,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL613508,Homo sapiens,DU-145,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52392,52392,,inactive,8586999,[],CHEMBL1964021,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614922,Homo sapiens,SK-MEL-5,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52393,52393,,inactive,8589531,[],CHEMBL1964025,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614021,Homo sapiens,Malme-3M,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52394,52394,,inactive,8685922,[],CHEMBL1964030,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL385,Homo sapiens,K562,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52395,52395,,inactive,8778900,[],CHEMBL1964037,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614213,Homo sapiens,OVCAR-3,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52396,52396,,inactive,8804321,[],CHEMBL1964040,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614177,Homo sapiens,MOLT-4,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52397,52397,,inactive,8806735,[],CHEMBL1964043,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614643,Homo sapiens,HOP-62,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52398,52398,,inactive,8927788,[],CHEMBL1964047,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL615022,Homo sapiens,U-251,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52399,52399,,inactive,8929642,[],CHEMBL1964045,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL613829,Homo sapiens,NCI/ADR-RES,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52400,52400,,inactive,8970711,[],CHEMBL1964048,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL612555,Homo sapiens,OVCAR-8,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52401,52401,,inactive,8990894,[],CHEMBL1964049,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614214,Homo sapiens,OVCAR-5,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52402,52402,,inactive,9015358,[],CHEMBL1964059,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614164,Homo sapiens,SNB-19,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52403,52403,,inactive,9114300,[],CHEMBL1964065,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614300,Homo sapiens,SR,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52404,52404,,inactive,9134282,[],CHEMBL1964063,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL400,Homo sapiens,MDA-MB-231,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52405,52405,,inactive,9187786,[],CHEMBL1964066,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614056,Homo sapiens,TK-10,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52406,52406,,inactive,9212811,[],CHEMBL1964072,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL612262,Homo sapiens,SW-620,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52407,52407,,inactive,9225497,[],CHEMBL1964075,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614387,Homo sapiens,NCI-H522,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52408,52408,,inactive,9314020,[],CHEMBL1964085,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614317,Homo sapiens,M14,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52409,52409,,inactive,9320400,[],CHEMBL1964077,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614709,Homo sapiens,KM12,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52410,52410,,inactive,9374831,[],CHEMBL1964087,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614803,Homo sapiens,NCI-H322M,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52411,52411,,inactive,9390428,[],CHEMBL1964088,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614882,Homo sapiens,RPMI-8226,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52412,52412,,inactive,9458432,[],CHEMBL1964091,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614051,Homo sapiens,OVCAR-4,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52413,52413,,inactive,9521398,[],CHEMBL1964092,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614096,Homo sapiens,LOX IMVI,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52414,52414,,inactive,9693353,[],CHEMBL1963844,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614917,Homo sapiens,SK-MEL-2,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52415,52415,,inactive,9749214,[],CHEMBL1963854,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL392,Homo sapiens,A549,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52416,52416,,inactive,9797840,[],CHEMBL1963866,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614451,Homo sapiens,SNB-75,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52417,52417,,inactive,9824692,[],CHEMBL1963860,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL613855,Homo sapiens,HCC 2998,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52418,52418,,inactive,9891330,[],CHEMBL1963868,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL612263,Homo sapiens,HCT-15,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52419,52419,,inactive,9925163,[],CHEMBL1963874,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL394,Homo sapiens,HCT-116,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52420,52420,,inactive,9962807,[],CHEMBL1963876,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL613977,Homo sapiens,SF-268,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52421,52421,,inactive,9980293,[],CHEMBL1963882,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL387,Homo sapiens,MCF7,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52422,52422,,inactive,9987155,[],CHEMBL1963880,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614487,Homo sapiens,EKVX,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52423,52423,,inactive,10104148,[],CHEMBL1963885,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL390,Homo sapiens,PC-3,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52424,52424,,inactive,10132247,[],CHEMBL1963900,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614361,Homo sapiens,T47D,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52425,52425,,inactive,10253786,[],CHEMBL1963901,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL396,Homo sapiens,NCI-H460,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52426,52426,,inactive,10282270,[],CHEMBL1963921,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614697,Homo sapiens,MDA-MB-435,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52427,52427,,inactive,10293427,[],CHEMBL1963911,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614067,Homo sapiens,CAKI-1,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52428,52428,,inactive,10353148,[],CHEMBL1963929,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL613984,Homo sapiens,IGROV-1,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52429,52429,,inactive,10367797,[],CHEMBL1963922,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614908,Homo sapiens,SF-295,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52430,52430,,inactive,10450541,[],CHEMBL1963945,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614645,Homo sapiens,Hs-578T,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52431,52431,,inactive,10475016,[],CHEMBL1963953,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL613102,Homo sapiens,786-0,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52432,52432,,inactive,10542060,[],CHEMBL1963961,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL382,Homo sapiens,CCRF-CEM,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52433,52433,,inactive,10594768,[],CHEMBL1963960,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL612796,Homo sapiens,UACC-257,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52434,52434,,inactive,10606394,[],CHEMBL1964004,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614740,Homo sapiens,NCI-H226,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52435,52435,,inactive,10708380,[],CHEMBL1964006,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL384,Homo sapiens,HT-29,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52436,52436,,inactive,10728654,[],CHEMBL1964007,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614919,Homo sapiens,SK-MEL-28,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52437,52437,,inactive,10769136,[],CHEMBL1964012,PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line. (Class of assay: confirmatory) ,F,,,BAO_0000189,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1626753,,7,1,,,GI50,nM,,100000.0,CHEMBL614561,Homo sapiens,COLO 205,9606.0,,,log GI50 (M),,UO_0000065,,-4.0
52438,52438,,active,11498259,[],CHEMBL2114775,PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,980215,,7,1,,,Potency,nM,,562.3,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,0.5623
52439,52439,,inactive,11561170,[],CHEMBL2114780,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,980215,,7,1,,,Potency,nM,,82.0,CHEMBL1293278,Homo sapiens,Geminin,9606.0,,,Potency,uM,UO_0000065,,0.082
52440,52440,,inconclusive,13006252,[],CHEMBL2354254,PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,1157591,,7,1,,,Potency,nM,,32642.7,CHEMBL1075138,Homo sapiens,Tyrosyl-DNA phosphodiesterase 1,9606.0,,,Potency,uM,UO_0000065,,32.6427
52441,52441,,inconclusive,14075317,[],CHEMBL3214953,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,980215,,7,1,,,Potency,nM,,28183.8,CHEMBL1795087,Homo sapiens,Ubiquitin carboxyl-terminal hydrolase 1,9606.0,,,Potency,uM,UO_0000065,,28.1838
52442,52442,,inconclusive,14328995,[],CHEMBL3215278,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL1201862,,,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,980215,,7,1,,,Potency,nM,,7519.3,CHEMBL3024,Homo sapiens,Serine/threonine-protein kinase PLK1,9606.0,,,Potency,uM,UO_0000065,,7.5193
52443,52443,,,16476919,[],CHEMBL3766221,Cytotoxicity against human HaCaT cells assessed as reduction in cell viability after 48 hrs by MTT assay,A,,,BAO_0000188,BAO_0000219,cell-based format,Cl.NCCS,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL3763053,Eur J Med Chem,2016.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://www.openphacts.org/units/Nanomolar,2755988,=,1,1,=,,EC50,nM,,309000.0,CHEMBL614392,Homo sapiens,HaCaT,9606.0,,,EC50,uM,UO_0000065,,309.0
52444,52444,,,16476926,[],CHEMBL3766222,"Dissociation constant, pKa of compound at pH 2 to 12 at 1 to 2 mg by potentiometric titration method",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,Cl.NCCS,,,CHEMBL3763053,Eur J Med Chem,2016.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,,2755988,=,1,0,=,,pKa,,,8.15,CHEMBL2362975,,No relevant target,,,,pKa,,,,8.15
52445,52445,,,16476933,[],CHEMBL3766223,"Octanol-water partition coefficient, log P of compound at pH 2 to 12 by pH metric analysis",P,,,BAO_0002130,BAO_0000100,small-molecule physicochemical format,Cl.NCCS,,,CHEMBL3763053,Eur J Med Chem,2016.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,,2755988,=,1,1,=,,LogP,,,0.06,CHEMBL2362975,,No relevant target,,,,logP,,,,0.06
52446,52446,,,16476940,[],CHEMBL3766224,"Lipophilicity, log D of compound at pH 7.4",P,,,BAO_0002129,BAO_0000100,small-molecule physicochemical format,Cl.NCCS,,,CHEMBL3763053,Eur J Med Chem,2016.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,,2755988,=,1,1,=,,LogD,,,-2.28,CHEMBL2362975,,No relevant target,,,,logD,,,,-2.28
52447,52447,,,16476944,[],CHEMBL3766226,Prodrug activation in human PT37 cells assessed as intracellular cysteamine-CMQT formation per mg protein at 20 uM after 6 hrs by HPLC analysis,A,,,BAO_0000179,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL3763053,Eur J Med Chem,2016.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,,2755988,=,1,0,=,,Drug metabolism,nmol,,0.84,CHEMBL612558,,ADMET,,,,Drug metabolism,nmol,UO_0000041,,0.84
52448,52448,,,16476945,[],CHEMBL3766227,Prodrug activation in human PT37 cells assessed as intracellular cysteamine-CMQT formation per mg protein at 20 uM after 24 hrs by HPLC analysis,A,,,BAO_0000179,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL3763053,Eur J Med Chem,2016.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,,2755988,=,1,0,=,,Drug metabolism,nmol,,0.22,CHEMBL612558,,ADMET,,,,Drug metabolism,nmol,UO_0000041,,0.22
52449,52449,,,16476952,[],CHEMBL3766229,Drug metabolism in water assessed as oxidation of cysteamine by measuring cysteamine-CMQT level at pH 4.66 at 0.01 M after 1 hr by HPLC-UV method,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,Cl.NCCS,,,CHEMBL3763053,Eur J Med Chem,2016.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://qudt.org/vocab/unit#Percent,2755988,=,1,0,=,,Drug metabolism,%,,50.0,CHEMBL2362975,,No relevant target,,,,Drug metabolism,%,UO_0000187,,50.0
52450,52450,,metabolite_notdetected,16476953,[],CHEMBL3766230,Drug metabolism in water assessed as oxidation of cysteamine by measuring cysteamine-CMQT level at pH 4.66 at 0.01 M after 3 hrs by HPLC-UV method,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,Cl.NCCS,,,CHEMBL3763053,Eur J Med Chem,2016.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,,2755988,,1,0,,,Drug metabolism,,,,CHEMBL2362975,,No relevant target,,,,Drug metabolism,,,,
52451,52451,,metabolite_detected,16476954,[],CHEMBL3766231,Prodrug activation in human PT37 cells assessed as intracellular cysteamine-CMQT formation at 20 uM after 2 hrs by HPLC analysis,A,,,BAO_0000179,BAO_0000219,cell-based format,Cl.NCCS,,,CHEMBL3763053,Eur J Med Chem,2016.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,,2755988,,1,0,,,Drug metabolism,,,,CHEMBL612558,,ADMET,,,,Drug metabolism,,,,
52452,52452,,,18829419,[],CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,Cl.NCCS,,,CHEMBL4303101,,2020.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://qudt.org/vocab/unit#Percent,3135917,=,52,1,=,,Inhibition,%,,-3.09,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition,%,UO_0000187,,-3.09
52453,52453,,,19963851,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20M  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,Cl.NCCS,,,CHEMBL4495564,,2020.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://qudt.org/vocab/unit#Percent,3350269,=,52,1,=,,Inhibition,%,,10.55,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,10.54982022
52454,52454,,,20148051,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,Cl.NCCS,,,CHEMBL4495565,,2020.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://qudt.org/vocab/unit#Percent,3368141,=,52,1,=,,Inhibition,%,,0.09,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,0.09
52455,52455,,,22079631,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,Cl.NCCS,,,CHEMBL4495565,,2020.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,http://qudt.org/vocab/unit#Percent,3368141,=,52,1,=,,Inhibition,%,,0.09,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,0.09
52456,52456,,Not Active,23203296,[],CHEMBL4821208,Inhibition of ALDH1A1 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cl.NCCS,,,CHEMBL4819056,Bioorg Med Chem Lett,2021.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,,3608586,,1,0,,,IC50,,,,CHEMBL3577,Homo sapiens,Aldehyde dehydrogenase 1A1,9606.0,,,IC50,,,,
52457,52457,,Not Active,23203313,[],CHEMBL4821209,Inhibition of ALDH2 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,Cl.NCCS,,,CHEMBL4819056,Bioorg Med Chem Lett,2021.0,,CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE,CHEMBL602,,0,,3608586,,1,0,,,IC50,,,,CHEMBL1935,Homo sapiens,Aldehyde dehydrogenase,9606.0,,,IC50,,,,
52458,52458,,,149758,[],CHEMBL700847,Percentage growth inhibition of Toxoplasma gondii at concentration of 2 ug/mL using an human myelomonocytic cell line THP-1,F,,,BAO_0000096,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1133348,Bioorg Med Chem Lett,2000.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,335766,=,1,0,=,,GI,%,,86.0,CHEMBL614245,Homo sapiens,THP-1,9606.0,,,GI,%,UO_0000187,,86.0
52459,52459,,,275904,[],CHEMBL648905,Minimum inhibitory concentration against Bacteroides fragilis ATCC 25285,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124461,J Med Chem,1989.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,7750,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,2.0
52460,52460,,,275905,[],CHEMBL652071,Minimum inhibitory concentration against Bacteroides thetaiotaomicron ATCC 29741,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124461,J Med Chem,1989.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,7750,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,8.0
52461,52461,,,275906,[],CHEMBL659032,Minimum inhibitory concentration against Clostridium perfringens ATCC 13124,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124461,J Med Chem,1989.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,7750,<,1,1,<,,MIC,ug.mL-1,,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.5
52462,52462,,,275907,[],CHEMBL656330,Minimum inhibitory concentration against Clostridium difficile ATCC 9689,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124461,J Med Chem,1989.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,7750,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,1.0
52463,52463,,,346884,[],CHEMBL652778,In vitro activity against Bacteroides fragilis (105AT25285),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,2.0
52464,52464,,,346885,[],CHEMBL652779,In vitro activity against Bacteroides fragilis (784),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,1.0
52465,52465,,,346886,[],CHEMBL652783,In vitro activity against Bacteroides fragilis (UC-2),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,0.5
52466,52466,,,346887,[],CHEMBL652780,In vitro activity against Bacteroides fragilis (SFM2906A),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,0.5
52467,52467,,,346888,[],CHEMBL652782,In vitro activity against Bacteroides fragilis (SFM2975-7),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,2.0
52468,52468,,,346889,[],CHEMBL652781,In vitro activity against Bacteroides fragilis (SFM2929-1),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,0.06
52469,52469,,,346890,[],CHEMBL652932,In vitro activity against Bacteroides thetaiotaomicron (SFM2975-2),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,0.5
52470,52470,,,346891,[],CHEMBL651589,In vitro activity against Bacteroides vulgatus(792),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,0.015
52471,52471,,,346892,[],CHEMBL651590,In vitro activity against Bacteroides vulgatus(SFBC 2375),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,0.015
52472,52472,,,346893,[],CHEMBL649662,In vitro activity against Bacteroides disiens (ATCC 29426),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL612235,Prevotella disiens,Prevotella disiens,28130.0,,,MIC,ug ml-1,UO_0000274,,0.015
52473,52473,,,346894,[],CHEMBL876545,In vitro activity against Bacteroides thetaiotaomicron (ATCC 29742),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,4.0
52474,52474,,,346895,[],CHEMBL652934,In vitro activity against Bacteroides thetaiotaomicron (106),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,4.0
52475,52475,,,346896,[],CHEMBL652936,In vitro activity against thetaiotaomicron (ATCC 29741),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,8.0
52476,52476,,,346897,[],CHEMBL859347,In vitro activity against Bacteroides melaninogenicus (ATCC 25845).,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC,ug ml-1,UO_0000274,,0.03
52477,52477,,,346898,[],CHEMBL652918,In vitro activity against Bacteroides loescheii (ATCC 15930).,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614607,Hoylesella loescheii,Hoylesella loescheii,840.0,,,MIC,ug ml-1,UO_0000274,,0.5
52478,52478,,,346899,[],CHEMBL648878,In vitro activity against Bacteroides bivius(B 6140),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,<,1,1,<,,MIC,ug.mL-1,,0.015,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,,MIC,ug ml-1,UO_0000274,,0.015
52479,52479,,,346900,[],CHEMBL681397,In vitro activity against Fusobacterium nucleatum (ATCC 25586),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC,ug ml-1,UO_0000274,,0.25
52480,52480,,,346901,[],CHEMBL680954,In vitro activity against Fusobacterium sp.(GS-10),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,,MIC,ug ml-1,UO_0000274,,0.12
52481,52481,,,346902,[],CHEMBL820804,In vitro activity against Veillonella parvula (ATCC 10790),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612244,Veillonella parvula,Veillonella parvula,29466.0,,,MIC,ug ml-1,UO_0000274,,0.06
52482,52482,,,346903,[],CHEMBL659020,In vitro activity against Clostridium perfringens (104AT13124),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.03
52483,52483,,,346904,[],CHEMBL659022,In vitro activity against Clostridium perfringens (SFBC 2026),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.25
52484,52484,,,346905,[],CHEMBL659021,In vitro activity against Clostridium perfringens (788),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.06
52485,52485,,,346906,[],CHEMBL657488,In vitro activity against Clostridium difficile (ATCC 9689),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,4.0
52486,52486,,,346907,[],CHEMBL660124,In vitro activity against Clostridium difficile (ATCC 17857),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,8.0
52487,52487,,,346908,[],CHEMBL660463,In vitro activity against Clostridium ramosum (7),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614971,Thomasclavelia ramosa,Thomasclavelia ramosa,1547.0,,,MIC,ug ml-1,UO_0000274,,1.0
52488,52488,,,346909,[],CHEMBL769562,In vitro activity against Propionibacterium acnes (132),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.06
52489,52489,,,346910,[],CHEMBL765431,In vitro activity against Peptococcus asaccharolyticus (ATCC 14963).,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC,ug ml-1,UO_0000274,,0.06
52490,52490,,,346911,[],CHEMBL765436,In vitro activity against Peptococcus magnus (ATCC 29328),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC,ug ml-1,UO_0000274,,1.0
52491,52491,,,346912,[],CHEMBL765445,In vitro activity against Peptostreptococcus sp.(TB-11),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614418,Peptostreptococcus,Peptostreptococcus,1257.0,,,MIC,ug ml-1,UO_0000274,,0.06
52492,52492,,,346913,[],CHEMBL760160,In vitro activity against Peptostreptococcus micros (ATCC 33270).,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,,MIC,ug ml-1,UO_0000274,,0.06
52493,52493,,,346914,[],CHEMBL764399,In vitro activity against Peptostreptococcus anaerobius (ATCC 27337),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1124180,J Med Chem,1988.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,65573,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC,ug ml-1,UO_0000274,,0.12
52494,52494,,,362217,[],CHEMBL693808,"Compound was evaluated for the cytotoxicity against human hepatocellular carcinoma, HepG2 (ATCC HB8065)",F,,,BAO_0000179,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1152061,Bioorg Med Chem Lett,1996.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Micromolar,133422,>,1,0,>,,MNTC,uM,,5000.0,CHEMBL395,Homo sapiens,HepG2,9606.0,,,MNTC,uM,UO_0000064,,5000.0
52495,52495,,,362218,[],CHEMBL695694,"Compound was evaluated for the cytotoxicity against human cervix epithelioid carcinoma, HeLa (ATCC CCL2)",F,,,BAO_0000179,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1152061,Bioorg Med Chem Lett,1996.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Micromolar,133422,=,1,0,=,,MNTC,uM,,1000.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,MNTC,uM,UO_0000064,,1000.0
52496,52496,,,362219,[],CHEMBL842631,Compound was evaluated for the cytotoxicity against human ocular lens epithelium (CECH).,F,,,BAO_0000179,BAO_0000221,tissue-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1152061,Bioorg Med Chem Lett,1996.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Micromolar,133422,=,1,0,=,,MNTC,uM,,1000.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MNTC,uM,UO_0000064,,1000.0
52497,52497,,,959728,[],CHEMBL646895,"Tested for zone of inhibition against Bacteroides fragilis UC6513 (1 mg/mL, 80 microL/12.7 mm)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Millimolar,128255,=,1,0,=,,Diameter of inhibition zone,mM,,30.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,Diameter of inhibition zone,mM,UO_0000063,,30.0
52498,52498,,,959729,[],CHEMBL660764,Tested for zone of inhibition against Clostridium perfringens UC6509,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Millimolar,128255,=,1,0,=,,Diameter of inhibition zone,mM,,24.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,Diameter of inhibition zone,mM,UO_0000063,,24.0
52499,52499,,,959730,[],CHEMBL810278,"Tested for zone of inhibition against Staphylococcus aureus UC6685 (1 mg/mL, 80 microL/6.5 mm)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Millimolar,128255,=,1,0,=,,Diameter of inhibition zone,mM,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Diameter of inhibition zone,mM,UO_0000063,,0.0
52500,52500,,,959731,[],CHEMBL810276,"Tested for zone of inhibition against Staphylococcus aureus UC3665 (1 mg/mL, 80 microL/12.7 mm)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Millimolar,128255,=,1,0,=,,Diameter of inhibition zone,mM,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Diameter of inhibition zone,mM,UO_0000063,,0.0
52501,52501,,Trace,959732,[],CHEMBL744953,"The compound (1 mg/mL, 80 microL/12.7 mm) was tested for zone of inhibition against Mycobacterium avium UC159; Tr = trace",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,128255,,1,0,,,Diameter of inhibition zone,,,,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,Diameter of inhibition zone,mM,,,
52502,52502,,,959733,[],CHEMBL813756,"Tested for zone of inhibition against Staphylococcus epidermidis UC719 (1 mg/mL, 80 microL/6.5 mm)",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Millimolar,128255,=,1,0,=,,Diameter of inhibition zone,mM,,22.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Diameter of inhibition zone,mM,UO_0000063,,22.0
52503,52503,,,959734,[],CHEMBL652068,Tested in vitro for its antibacterial activity against Bacteroides thetaiotaomicron UC 9014[clindamycin 2 micro g/mL],F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128255,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,4.0
52504,52504,,,959735,[],CHEMBL652921,Tested in vitro for its antibacterial activity against Bacteroides melaninogenicus UC 6523,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128255,<,1,1,<,,MIC,ug.mL-1,,0.12,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC,ug ml-1,UO_0000274,,0.12
52505,52505,,,959736,[],CHEMBL651778,Tested in vitro for its antibacterial activity against Bacteroides fragilis UC9370 [clindamycin 1 micro g/mL],F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128255,<,1,1,<,,MIC,ug.mL-1,,0.12,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,0.12
52506,52506,,,959737,[],CHEMBL646892,Tested in vitro for its antibacterial activity against Bacteroides distasonis UC6518,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128255,<,1,1,<,,MIC,ug.mL-1,,0.12,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC,ug ml-1,UO_0000274,,0.12
52507,52507,,,959738,[],CHEMBL681402,Tested in vitro for its antibacterial activity against Fusobacterium nucleatum UC6324,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128255,<,1,1,<,,MIC,ug.mL-1,,0.12,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC,ug ml-1,UO_0000274,,0.12
52508,52508,,,959739,[],CHEMBL769568,Tested in vitro for its antibacterial activity against Propionibacterium acnes UC6564,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128255,<,1,1,<,,MIC,ug.mL-1,,0.12,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.12
52509,52509,,,959740,[],CHEMBL659042,Tested in vitro for its antibacterial activity against Clostridium perfringens UC6509,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128255,<,1,1,<,,MIC,ug.mL-1,,0.12,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.12
52510,52510,,,959741,[],CHEMBL765443,Tested in vitro for its antibacterial activity against Peptococcus variabilis UC6320,F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128255,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,1.0
52511,52511,,Not Determined,959742,[],CHEMBL807908,The compound was tested in vitro for its antibacterial activity against Streptococcus pyogenes UC152; not tested,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128255,,1,0,,,MIC,ug.mL-1,,,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,
52512,52512,,Not Determined,959743,[],CHEMBL673894,The compound was tested in vitro for its antibacterial activity against Escherichia coli UC9379; not tested,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150488,Bioorg Med Chem Lett,1993.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,128255,,1,0,,,MIC,ug.mL-1,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,
52513,52513,,,988444,[],CHEMBL807852,In vitro antibacterial activity for minimum inhibition concentration (MIC) required to inhibit growth of Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
52514,52514,,,988445,[],CHEMBL807201,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6686),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
52515,52515,,,988446,[],CHEMBL807202,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6687),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.025
52516,52516,,,988447,[],CHEMBL807203,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6688),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
52517,52517,,,988448,[],CHEMBL807204,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6689),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
52518,52518,,,988449,[],CHEMBL807205,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6690),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.025
52519,52519,,,988450,[],CHEMBL807206,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6691),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
52520,52520,,,988451,[],CHEMBL807207,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6692),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
52521,52521,,,988452,[],CHEMBL807208,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6693),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
52522,52522,,,988453,[],CHEMBL807209,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6694),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
52523,52523,,,988454,[],CHEMBL807210,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6695),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
52524,52524,,,988455,[],CHEMBL807211,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6696),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.1
52525,52525,,,988456,[],CHEMBL807200,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.6675),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
52526,52526,,,988457,[],CHEMBL880102,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.76),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
52527,52527,,,988458,[],CHEMBL809868,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.570),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
52528,52528,,,988459,[],CHEMBL807199,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.571),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
52529,52529,,,988460,[],CHEMBL856977,In vitro antibacterial activity against the aerobic Staphylococcus aureus (Strain UC no.746),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.05
52530,52530,,,988461,[],CHEMBL812965,In vitro antibacterial activity against the aerobic Staphylococcus epidermidis (Strain UC no.719),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.1
52531,52531,,,988462,[],CHEMBL858060,In vitro antibacterial activity against the aerobic Staphylococcus epidermidis (Strain UC no.3389),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.1
52532,52532,,,988463,[],CHEMBL811547,In vitro antibacterial activity against the aerobic Staphylococcus faecalis (Strain UC no.694),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,25.0
52533,52533,,,988464,[],CHEMBL806111,In vitro antibacterial activity against the aerobic Staphylococcus pyogenes (Strain UC no.152),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,<,1,1,<,,MIC,ug.mL-1,,0.012,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.012
52534,52534,,,988465,[],CHEMBL804514,In vitro antibacterial activity against the aerobic Staphylococcus mitis (Strain UC no.153),F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,<,1,1,<,,MIC,ug.mL-1,,0.012,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,0.012
52535,52535,,,988466,[],CHEMBL804615,In vitro antibacterial activity against the aerobic Staphylococcus mitis (Strain UC no.871),F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,<,1,1,<,,MIC,ug.mL-1,,0.012,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,0.012
52536,52536,,,988467,[],CHEMBL858059,In vitro antibacterial activity against the aerobic Staphylococcus pneumoniae I(Strain UC no.41),F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,<,1,1,<,,MIC,ug.mL-1,,0.012,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,0.012
52537,52537,,,988468,[],CHEMBL806106,In vitro antibacterial activity against the aerobic Staphylococcus pneumoniae III(Strain UC no.3213),F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,<,1,1,<,,MIC,ug.mL-1,,0.012,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,0.012
52538,52538,,,988469,[],CHEMBL681228,In vitro antibacterial activity against the aerobic Escherichia coli (Strain UC no.45),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
52539,52539,,,988470,[],CHEMBL767771,In vitro antibacterial activity against the aerobic Proteus vulgaris (Strain UC no.93),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,25.0
52540,52540,,,988471,[],CHEMBL700064,In vitro antibacterial activity against the aerobic Klebsiella pneumoniae (Strain UC no.58),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,12.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,12.5
52541,52541,,,988472,[],CHEMBL801483,In vitro antibacterial activity against the aerobic Salmonella schottmuelleri (Strain UC no.126),F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,25.0
52542,52542,,,988473,[],CHEMBL766580,In vitro antibacterial activity against the aerobic Pseudomonas aeruginosa (Strain UC no.95),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,>,1,1,>,,MIC,ug.mL-1,,25.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,25.0
52543,52543,,,988474,[],CHEMBL760390,In vitro antibacterial activity against the aerobic Pasteurella multocida (Strain UC no.264),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,3.9,CHEMBL614409,Pasteurella multocida,Pasteurella multocida,747.0,,,MIC,ug ml-1,UO_0000274,,3.9
52544,52544,,,988475,[],CHEMBL875935,In vitro antibacterial activity against the anaerobic Bacteroides fragilis (Strain UC no.6513),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,0.06
52545,52545,,,988476,[],CHEMBL652784,In vitro antibacterial activity against the anaerobic Bacteroides fragilis (Strain UC no.6428),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,0.12
52546,52546,,,988477,[],CHEMBL648894,In vitro antibacterial activity against the anaerobic Bacteroides fragilis (Strain UC no.6864),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,3.9,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,3.9
52547,52547,,,988478,[],CHEMBL650319,In vitro antibacterial activity against the anaerobic Bacteroides fragilis (Strain UC no.6862),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,7.8,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,7.8
52548,52548,,,988479,[],CHEMBL652937,In vitro antibacterial activity against the anaerobic Bacteroides thetaiotaomicron (Strain UC no.6512),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,2.0
52549,52549,,,988480,[],CHEMBL875429,In vitro antibacterial activity against the anaerobic Bacteroides distasonis (Strain UC no.6518),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC,ug ml-1,UO_0000274,,0.12
52550,52550,,,988481,[],CHEMBL652919,In vitro antibacterial activity against the anaerobic Bacteroides melaninogenicus (Strain UC no.6326),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,,MIC,ug ml-1,UO_0000274,,0.06
52551,52551,,,988482,[],CHEMBL659023,In vitro antibacterial activity against the anaerobic Clostridium perfringens (Strain UC no.247),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.06
52552,52552,,,988483,[],CHEMBL659024,In vitro antibacterial activity against the anaerobic Clostridium perfringens (Strain UC no.6509),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC,ug ml-1,UO_0000274,,0.06
52553,52553,,,988484,[],CHEMBL656340,In vitro antibacterial activity against the anaerobic Clostridium novyi B(Strain UC no.6329),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612635,Clostridium novyi,Clostridium novyi,1542.0,,,MIC,ug ml-1,UO_0000274,,0.06
52554,52554,,,988485,[],CHEMBL660470,In vitro antibacterial activity against the anaerobic Clostridium tertium(Strain UC no.6508),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,7.8,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,,MIC,ug ml-1,UO_0000274,,7.8
52555,52555,,,988486,[],CHEMBL660120,In vitro antibacterial activity against the anaerobic Clostridium cadaveris (Strain UC no.6510),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL614970,Clostridium cadaveris,Clostridium cadaveris,1529.0,,,MIC,ug ml-1,UO_0000274,,0.03
52556,52556,,,988487,[],CHEMBL660468,In vitro antibacterial activity against the anaerobic Clostridium sordellii (Strain UC no.6505),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613072,Paeniclostridium sordellii,Paeniclostridium sordellii,1505.0,,,MIC,ug ml-1,UO_0000274,,2.0
52557,52557,,,988488,[],CHEMBL660471,In vitro antibacterial activity against the anaerobic Clostridium tetani(Strain UC no.6521),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,0.03
52558,52558,,,988489,[],CHEMBL660118,In vitro antibacterial activity against the anaerobic Clostridium botulinum A(Strain UC no.6506),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614963,Clostridium botulinum,Clostridium botulinum,1491.0,,,MIC,ug ml-1,UO_0000274,,0.25
52559,52559,,,988490,[],CHEMBL660117,In vitro antibacterial activity against the anaerobic Clostridium bifermentans (Strain UC no.6507),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614962,Paraclostridium bifermentans,Paraclostridium bifermentans,1490.0,,,MIC,ug ml-1,UO_0000274,,0.5
52560,52560,,,988491,[],CHEMBL656323,In vitro antibacterial activity against the anaerobic Clostridium difficile (Strain UC no.6834),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,7.8,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,7.8
52561,52561,,,988492,[],CHEMBL656324,In vitro antibacterial activity against the anaerobic Clostridium difficile (Strain UC no.6857),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,250.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,250.0
52562,52562,,,988493,[],CHEMBL656325,In vitro antibacterial activity against the anaerobic Clostridium difficile (Strain UC no.6858),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,3.9,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,3.9
52563,52563,,,988494,[],CHEMBL656326,In vitro antibacterial activity against the anaerobic Clostridium difficile (Strain UC no.6860),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,500.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,500.0
52564,52564,,,988495,[],CHEMBL656327,In vitro antibacterial activity against the anaerobic Clostridium difficile (Strain UC no.6861),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,3.9,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,3.9
52565,52565,,,988496,[],CHEMBL768138,In vitro antibacterial activity against the anaerobic Propionibacterium acnes(Strain UC no.6564),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.06
52566,52566,,,988497,[],CHEMBL768139,In vitro antibacterial activity against the anaerobic Propionibacterium acnes(Strain UC no.6575),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.03
52567,52567,,,988498,[],CHEMBL680093,In vitro antibacterial activity against the anaerobic Eubacterium limosum(Strain UC no.6515),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613084,Eubacterium limosum,Eubacterium limosum,1736.0,,,MIC,ug ml-1,UO_0000274,,2.0
52568,52568,,,988499,[],CHEMBL680092,In vitro antibacterial activity against the anaerobic Eubacterium lentum(Strain UC no.6522),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,,MIC,ug ml-1,UO_0000274,,0.5
52569,52569,,,988500,[],CHEMBL636962,In vitro antibacterial activity against the anaerobic Actinomyces naeslundii (Strain UC no.5920),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,,MIC,ug ml-1,UO_0000274,,0.25
52570,52570,,,988501,[],CHEMBL681399,In vitro antibacterial activity against the anaerobic Fusobacterium nucleatum (Strain UC no.6516),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC,ug ml-1,UO_0000274,,0.12
52571,52571,,,988502,[],CHEMBL681398,In vitro antibacterial activity against the anaerobic Fusobacterium nucleatum (Strain UC no.6324),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,,MIC,ug ml-1,UO_0000274,,0.06
52572,52572,,,988503,[],CHEMBL680959,In vitro antibacterial activity against the anaerobic Fusobacterium varium(Strain UC no.6052),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,15.6,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,,MIC,ug ml-1,UO_0000274,,15.6
52573,52573,,,988504,[],CHEMBL681394,In vitro antibacterial activity against the anaerobic Fusobacterium necrophorum (Strain UC no.6568),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,,MIC,ug ml-1,UO_0000274,,0.06
52574,52574,,,988505,[],CHEMBL765432,In vitro antibacterial activity against the anaerobic Peptococcus asaccharolyticus (Strain UC no.6214),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC,ug ml-1,UO_0000274,,0.5
52575,52575,,,988506,[],CHEMBL765437,In vitro antibacterial activity against the anaerobic Peptococcus magnus(Strain UC no.6258),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,,MIC,ug ml-1,UO_0000274,,0.06
52576,52576,,,988507,[],CHEMBL765270,In vitro antibacterial activity against the anaerobic Peptoccus aerogenes (Strain UC no.6319),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,,MIC,ug ml-1,UO_0000274,,0.03
52577,52577,,,988508,[],CHEMBL764400,In vitro antibacterial activity against the anaerobic Peptostreptococcus anaerobius(Strain UC no.6321),F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,126422,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC,ug ml-1,UO_0000274,,0.12
52578,52578,,,988509,[],CHEMBL735271,In vivo antibacterial activity against Staphylococcus aureus (UC no 76) infected mice after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,CD50,mg kg-1,,5.7,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,5.7
52579,52579,,,988510,[],CHEMBL735276,In vivo antibacterial activity against Streptococcus pyogenes(UC 152) infected mice after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,CD50,mg kg-1,,2.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,2.3
52580,52580,,,988511,[],CHEMBL883116,In vivo antibacterial activity against Streptococcus pneumoniae I (UC 41) infected mice after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,CD50,mg kg-1,,40.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,40.0
52581,52581,,,988512,[],CHEMBL735274,In vivo antibacterial activity against Streptococcus pneumoniae IIII(UC 3213) infected mice after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,CD50,mg kg-1,,20.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,20.0
52582,52582,,,988513,[],CHEMBL735264,In vivo antibacterial activity against Klebsiella pneumoniae (UC 58) infected mice after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,>,1,0,>,,CD50,mg kg-1,,320.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,320.0
52583,52583,,,988514,[],CHEMBL735269,In vivo antibacterial activity against Proteus vulgaris (UC no 347) infected mice after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,>,1,0,>,,CD50,mg kg-1,,160.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,160.0
52584,52584,,,988515,[],CHEMBL731294,In vivo antibacterial activity against Escherichia coli (UC no 311) infected mice after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,>,1,0,>,,CD50,mg kg-1,,160.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,160.0
52585,52585,,,988516,[],CHEMBL735266,In vivo antibacterial activity against Pasteurella multocida (UC no 264) infected mice after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,>,1,0,>,,CD50,mg kg-1,,160.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,160.0
52586,52586,,,988517,[],CHEMBL731293,In vivo antibacterial activity against Bacteroides fragilis (UC no 6428) infected mice after sc administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,CD50,mg kg-1,,14.4,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,14.4
52587,52587,,,988518,[],CHEMBL735268,In vivo antibacterial activity against Plasmodium berghei infected mice (Mus musculus) after subcutaneous administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,CD50,mg kg-1,,53.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,53.0
52588,52588,,,988519,[],CHEMBL735272,In vivo antibacterial activity against Staphylococcus aureus(UC 76) infected mice after oral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,CD50,mg kg-1,,12.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,12.3
52589,52589,,,988520,[],CHEMBL735275,In vivo antibacterial activity against Streptococcus pyogenes(UC 152) infected mice after oral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,CD50,mg kg-1,,12.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,12.3
52590,52590,,,988521,[],CHEMBL735273,In vivo antibacterial activity against Streptococcus pneumoniae I(UC 41) infected mice after oral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,CD50,mg kg-1,,45.5,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,45.5
52591,52591,,,988522,[],CHEMBL878388,In vivo antibacterial activity against Streptococcus pneumoniae III(UC 3213) infected mice after oral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,CD50,mg kg-1,,37.9,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,37.9
52592,52592,,,988523,[],CHEMBL735265,In vivo antibacterial activity against Klebsiella pneumoniae(UC 58) infected mice after oral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,>,1,0,>,,CD50,mg kg-1,,400.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,400.0
52593,52593,,,988524,[],CHEMBL735270,In vivo antibacterial activity against Proteus vulgaris(UC 347) infected mice after oral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,>,1,0,>,,CD50,mg kg-1,,400.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,400.0
52594,52594,,,988525,[],CHEMBL731295,In vivo antibacterial activity against Escherichia coli(UC 311) infected mice after oral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,>,1,0,>,,CD50,mg kg-1,,400.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,400.0
52595,52595,,,988526,[],CHEMBL735267,In vivo antibacterial activity against Pasteurella multocida(UC 264) infected mice after oral administration,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,>,1,0,>,,CD50,mg kg-1,,400.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,CD50,mg kg-1,UO_0000308,,400.0
52596,52596,,,988527,[],CHEMBL737366,"Bioactivity in abscess, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 15 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,A,ug (g of abscess)-1,,16.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,A,ug (g of abscess)-1,,,16.0
52597,52597,,,988528,[],CHEMBL733901,"Bioactivity in blood, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 15 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,B,ug (g of abscess)-1,,17.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,B,ug (g of abscess)-1,,,17.0
52598,52598,,,988529,[],CHEMBL737368,"Bioactivity in abscess, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 30 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,A,ug (g of abscess)-1,,22.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,A,ug (g of abscess)-1,,,22.0
52599,52599,,,988530,[],CHEMBL733903,"Bioactivity in blood, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 30 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,B,ug (g of abscess)-1,,23.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,B,ug (g of abscess)-1,,,23.0
52600,52600,,,988531,[],CHEMBL731865,"Bioactivity in abscess, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 45 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,A,ug (g of abscess)-1,,26.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,A,ug (g of abscess)-1,,,26.0
52601,52601,,,988532,[],CHEMBL732234,"Bioactivity in blood, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 45 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,B,ug (g of abscess)-1,,17.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,B,ug (g of abscess)-1,,,17.0
52602,52602,,,988533,[],CHEMBL731866,"Bioactivity in abscess, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 60 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,A,ug (g of abscess)-1,,21.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,A,ug (g of abscess)-1,,,21.0
52603,52603,,,988534,[],CHEMBL732235,"Bioactivity in blood, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 60 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,B,ug (g of abscess)-1,,12.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,B,ug (g of abscess)-1,,,12.0
52604,52604,,,988535,[],CHEMBL731867,"Bioactivity in abscess, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 90 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,A,ug (g of abscess)-1,,13.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,A,ug (g of abscess)-1,,,13.0
52605,52605,,,988536,[],CHEMBL732236,"Bioactivity in blood, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 90 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,B,ug (g of abscess)-1,,4.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,B,ug (g of abscess)-1,,,4.0
52606,52606,,,988537,[],CHEMBL737365,"Bioactivity in abscess, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 120 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,A,ug (g of abscess)-1,,9.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,A,ug (g of abscess)-1,,,9.0
52607,52607,,,988538,[],CHEMBL733900,"Bioactivity in blood, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 120 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,B,ug (g of abscess)-1,,3.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,B,ug (g of abscess)-1,,,3.0
52608,52608,,,988539,[],CHEMBL737367,"Bioactivity in abscess, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 150 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,A,ug (g of abscess)-1,,8.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,A,ug (g of abscess)-1,,,8.0
52609,52609,,,988540,[],CHEMBL733902,"Bioactivity in blood, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 150 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,B,ug (g of abscess)-1,,1.4,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,B,ug (g of abscess)-1,,,1.4
52610,52610,,,988541,[],CHEMBL731864,"Bioactivity in abscess, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 360 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,A,ug (g of abscess)-1,,3.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,A,ug (g of abscess)-1,,,3.0
52611,52611,,,988542,[],CHEMBL733904,"Bioactivity in blood, in Bacteroides fragilis infected mice following subcutaneous dose of 200 mg/kg after 360 mins of bleeding",F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1122773,J Med Chem,1984.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,126422,=,1,0,=,,B,ug (g of abscess)-1,,0.2,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,B,ug (g of abscess)-1,,,0.2
52612,52612,,,1827815,[],CHEMBL912647,Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 48 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142150,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Nanomolar,625660,=,1,1,=,,IC50,nM,,288400.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,288.4
52613,52613,,,1827816,[],CHEMBL912647,Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Nanomolar,625660,=,1,1,=,,MIC90,nM,,537000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,MIC90,uM,UO_0000065,,537.0
52614,52614,,,1827842,[],CHEMBL912648,Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 96 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,8.89,0,http://www.openphacts.org/units/Nanomolar,625660,=,1,1,=,,IC50,nM,,1.3,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,0.0013
52615,52615,,,1827843,[],CHEMBL912648,Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 96 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Nanomolar,625660,=,1,1,=,,MIC90,nM,,6000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,MIC90,uM,UO_0000065,,6.0
52616,52616,,Not Active,1827918,[],CHEMBL912649,Decrease in Plasmodium falciparum FCK2 in erythrocytes at 5 uM after 84 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,625660,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
52617,52617,,,1827990,[],CHEMBL912652,Reduction in Plasmodium falciparum FCK2 in human blood cell culture after 96 hrs,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,625660,=,1,0,=,,Activity,%,,10.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,10.0
52618,52618,,Not Active,1827993,[],CHEMBL912653,Reduction in Plasmodium falciparum FCK2 in human erythrocyte culture after 48 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,625660,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
52619,52619,,,1827996,[],CHEMBL912654,Reduced apicoplast genome copy number in Plasmodium falciparum FCK2 after 48 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,625660,=,1,0,=,,Activity,,,0.65,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,0.65
52620,52620,,,1827997,[],CHEMBL912038,Reduced apicoplast genome copy number in Plasmodium falciparum FCK2 after 96 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,625660,=,1,0,=,,Activity,,,0.42,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,0.42
52621,52621,,,1828057,[],CHEMBL912039,Reduced apicoplast DNA/nuclear DNA ratio in Plasmodium falciparum FCK2 at 10 uM after 72 hrs by competitive PCR,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,625660,=,1,0,=,,Activity,,,0.4,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,0.4
52622,52622,,Not Active,1828123,[],CHEMBL912046,"Inhibition of fatty acid biosynthesis in Plasmodium falciparum FCK2 as [1,2-14C]acetate uptake during first asexual cycle at 10 uM after 24 hrs",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142150,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,625660,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
52623,52623,,,1828344,[],CHEMBL853485,Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 595,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625683,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
52624,52624,,,1828351,[],CHEMBL853486,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5737,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625683,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
52625,52625,,,1828358,[],CHEMBL853487,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5739,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625683,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
52626,52626,,,1828365,[],CHEMBL853488,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2513,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625683,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
52627,52627,,,1828372,[],CHEMBL854617,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2530,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625683,<=,1,1,<=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
52628,52628,,,1828379,[],CHEMBL854618,Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 2514,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625683,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
52629,52629,,,1828386,[],CHEMBL854619,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5735,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625683,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
52630,52630,,,1828393,[],CHEMBL854620,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5736,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625683,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
52631,52631,,,1828400,[],CHEMBL854621,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5733,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625683,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
52632,52632,,,1828407,[],CHEMBL854622,Antibacterial activity against vancomycin-resistant Staphylococcus aureus isolate 5734,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142154,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625683,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
52633,52633,,,1828625,[],CHEMBL909678,Antibacterial activity against Pneumococcus DAW12 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52634,52634,,,1828627,[],CHEMBL909679,Antibacterial activity against Pneumococcus DAW13 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52635,52635,,,1828629,[],CHEMBL909680,Antibacterial activity against Pneumococcus DAW14 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52636,52636,,,1828633,[],CHEMBL909676,Antibacterial activity against Pneumococcus DAW2 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52637,52637,,,1828635,[],CHEMBL909675,Antibacterial activity against Pneumococcus DAW6 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.038,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.038
52638,52638,,,1828637,[],CHEMBL909674,Antibacterial activity against Pneumococcus DAW8 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52639,52639,,,1828639,[],CHEMBL909677,Antibacterial activity against Pneumococcus DAW9 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
52640,52640,,,1828946,[],CHEMBL908743,Inhibition of metabolic activity in primary human osteoblasts in presence of 10% FCS,F,,,BAO_0080001,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,=,1,0,=,,IC20,ug ml-1,,20.0,CHEMBL612582,,Osteoblast,,,,IC20,ug ml-1,UO_0000274,,20.0
52641,52641,,,1828954,[],CHEMBL908125,Cytotoxicity against primary human osteoblasts at 400 ug/ml assessed as LDH release after 24 hrs,A,,,BAO_0001103,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,625758,=,1,0,=,,Activity,%,,10.0,CHEMBL612558,,ADMET,,,,Activity,%,UO_0000187,,10.0
52642,52642,,Active,1828979,[],CHEMBL909777,Decrease in lactate production in MG63 cells by ELISA,F,,,BAO_0000375,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,625758,,1,0,,,Activity,,,,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,Activity,,,,
52643,52643,,Active,1828980,[],CHEMBL909778,Decrease in lactate production in HeLa cells by ELISA,F,,,BAO_0000375,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,625758,,1,0,,,Activity,,,,CHEMBL399,Homo sapiens,HeLa,9606.0,,,Activity,,,,
52644,52644,,Active,1828981,[],CHEMBL909779,Increase in lactate production in primary human osteoblasts by ELISA relative to control,F,,,BAO_0000375,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,625758,,1,0,,,Activity,,,,CHEMBL612582,,Osteoblast,,,,Activity,,,,
52645,52645,,,1828982,[],CHEMBL909780,Increase in lactate production in MG63 cells at 400 ug/ml by ELISA relative to control,F,,,BAO_0001103,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,625758,=,1,0,=,,Activity,%,,60.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,Activity,%,UO_0000187,,60.0
52646,52646,,Active,1829002,[],CHEMBL909785,Antiproliferative effect against primary human osteoblasts in presence of 10% FCS,F,,,BAO_0000375,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,625758,,1,0,,,Activity,,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,,,,
52647,52647,,,1829093,[],CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,=,1,0,=,,IC20,ug ml-1,,40.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC20,ug ml-1,UO_0000274,,40.0
52648,52648,,,1829094,[],CHEMBL909765,Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,=,1,1,=,,IC50,ug.mL-1,,150.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,IC50,ug ml-1,UO_0000274,,150.0
52649,52649,,,1829095,[],CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,=,1,0,=,,IC20,ug ml-1,,340.0,CHEMBL612582,,Osteoblast,,,,IC20,ug ml-1,UO_0000274,,340.0
52650,52650,,,1829096,[],CHEMBL909766,Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,>,1,1,>,,IC50,ug.mL-1,,400.0,CHEMBL612582,,Osteoblast,,,,IC50,ug ml-1,UO_0000274,,400.0
52651,52651,,,1829097,[],CHEMBL909767,Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,=,1,0,=,,IC20,ug ml-1,,160.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC20,ug ml-1,UO_0000274,,160.0
52652,52652,,,1829098,[],CHEMBL909767,Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,=,1,1,=,,IC50,ug.mL-1,,250.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC50,ug ml-1,UO_0000274,,250.0
52653,52653,,,1829099,[],CHEMBL909768,Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,>,1,1,>,,IC50,ug.mL-1,,400.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC50,ug ml-1,UO_0000274,,400.0
52654,52654,,,1829100,[],CHEMBL909768,Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,=,1,0,=,,IC20,ug ml-1,,200.0,CHEMBL614347,Homo sapiens,MG-63,9606.0,,,IC20,ug ml-1,UO_0000274,,200.0
52655,52655,,,1829101,[],CHEMBL909769,Antiproliferative effect against HeLa cells after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,=,1,0,=,,IC20,ug ml-1,,230.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC20,ug ml-1,UO_0000274,,230.0
52656,52656,,,1829102,[],CHEMBL909769,Antiproliferative effect against HeLa cells after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,>,1,1,>,,IC50,ug.mL-1,,400.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,ug ml-1,UO_0000274,,400.0
52657,52657,,,1829103,[],CHEMBL909770,Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs,F,,,BAO_0000190,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,=,1,1,=,,IC50,ug.mL-1,,200.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC50,ug ml-1,UO_0000274,,200.0
52658,52658,,,1829104,[],CHEMBL909770,Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs,F,,,BAO_0080001,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142165,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625758,=,1,0,=,,IC20,ug ml-1,,80.0,CHEMBL399,Homo sapiens,HeLa,9606.0,,,IC20,ug ml-1,UO_0000274,,80.0
52659,52659,,,1829574,[],CHEMBL909681,Antibacterial activity against Pneumococcus DAW15 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.38
52660,52660,,,1829576,[],CHEMBL909682,Antibacterial activity against Pneumococcus DAW19 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.19
52661,52661,,,1829578,[],CHEMBL909683,Antibacterial activity against Pneumococcus DAW22 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
52662,52662,,,1829580,[],CHEMBL909684,Antibacterial activity against Pneumococcus DAW24 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52663,52663,,,1829582,[],CHEMBL909685,Antibacterial activity against Pneumococcus DAW26 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52664,52664,,,1829584,[],CHEMBL909686,Antibacterial activity against Pneumococcus DAW27 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
52665,52665,,,1829586,[],CHEMBL909687,Antibacterial activity against Pneumococcus DAW51 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52666,52666,,,1829588,[],CHEMBL911454,Antibacterial activity against Pneumococcus DAW53 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52667,52667,,,1829590,[],CHEMBL911455,Antibacterial activity against Pneumococcus DAW57 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
52668,52668,,,1829592,[],CHEMBL911456,Antibacterial activity against Pneumococcus DAW61 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
52669,52669,,,1829595,[],CHEMBL911457,Antibacterial activity against Pneumococcus DAW62 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.38
52670,52670,,,1829598,[],CHEMBL911458,Antibacterial activity against Pneumococcus DAW65 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52671,52671,,,1829599,[],CHEMBL911459,Antibacterial activity against Pneumococcus DAW66 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52672,52672,,,1829600,[],CHEMBL911460,Antibacterial activity against Pneumococcus DAW67 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.19
52673,52673,,,1829602,[],CHEMBL911461,Antibacterial activity against Pneumococcus DAW68 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.38
52674,52674,,,1829604,[],CHEMBL911462,Antibacterial activity against Pneumococcus DAW70 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.38
52675,52675,,,1829606,[],CHEMBL911463,Antibacterial activity against Pneumococcus DAW75 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
52676,52676,,,1829608,[],CHEMBL911464,Antibacterial activity against Pneumococcus DAW86 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52677,52677,,,1829610,[],CHEMBL911465,Antibacterial activity against Pneumococcus CDC001 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.19
52678,52678,,,1829612,[],CHEMBL911466,Antibacterial activity against Pneumococcus CDC013 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.19
52679,52679,,,1829614,[],CHEMBL911467,Antibacterial activity against Pneumococcus CDC018 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
52680,52680,,,1829616,[],CHEMBL911468,Antibacterial activity against Pneumococcus CDC020 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.19
52681,52681,,,1829618,[],CHEMBL911469,Antibacterial activity against Pneumococcus CDC023 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
52682,52682,,,1829620,[],CHEMBL911470,Antibacterial activity against Pneumococcus CDC050 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52683,52683,,,1829622,[],CHEMBL911471,Antibacterial activity against Pneumococcus CDC063 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52684,52684,,,1829624,[],CHEMBL911472,Antibacterial activity against Pneumococcus CDC068 isolated from sickle cell disease patient,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142146,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,625630,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52685,52685,,,1833692,[],CHEMBL856444,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolates from skin or soft tissue infection outpatients,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142184,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,625858,=,1,0,=,,Activity,%,,48.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,48.2
52686,52686,,,1833700,[],CHEMBL855426,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolates from skin or soft tissue infection outpatients,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142184,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,625858,=,1,0,=,,Activity,%,,7.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,7.0
52687,52687,,,1848546,[],CHEMBL919152,Antimicrobial activity against Streptococcus pneumoniae BSF-11524 isolate with erm(B) and L4 mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632127,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
52688,52688,,,1848553,[],CHEMBL919153,Antimicrobial activity against Streptococcus pneumoniae PC13 transformants,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632127,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
52689,52689,,,1848560,[],CHEMBL919154,Antimicrobial activity against Streptococcus pneumoniae PC13 isolate with erm(B) mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632127,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
52690,52690,,,1848567,[],CHEMBL919155,Antimicrobial activity against Streptococcus pneumoniae PC13 isolate with L4 mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632127,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
52691,52691,,,1848574,[],CHEMBL919156,Antimicrobial activity against Streptococcus pneumoniae PC13 isolate with L4 69GTG71 to TPS mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632127,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
52692,52692,,,1848581,[],CHEMBL919157,Antimicrobial activity against Streptococcus pneumoniae R6 transformants,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632127,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
52693,52693,,,1848588,[],CHEMBL919158,Antimicrobial activity against Streptococcus pneumoniae R6 with L4 mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632127,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
52694,52694,,,1848595,[],CHEMBL919159,Antimicrobial activity against Streptococcus pneumoniae R6 with L4 69GTG71 to TPS mutation,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142089,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632127,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.094
52695,52695,,,1848826,[],CHEMBL914567,Antimicrobial activity against Haemophilus influenzae NB65044 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142096,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632168,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
52696,52696,,,1848828,[],CHEMBL914568,Antimicrobial activity against Haemophilus influenzae CDS01 mutant with acrB insertional inactivation by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142096,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632168,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
52697,52697,,,1848830,[],CHEMBL914569,Antimicrobial activity against Haemophilus influenzae CDS23 mutant overexpressing Def by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142096,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632168,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
52698,52698,,,1848832,[],CHEMBL914570,Antimicrobial activity against Haemophilus influenzae CDS40 mutant with acrB insertional inactivation by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1142096,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,632168,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.5
52699,52699,,,1866403,[],CHEMBL920153,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed by relative light units after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Nanomolar,634686,>,1,1,>,,MIC,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,128.0
52700,52700,,,1866432,[],CHEMBL920154,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed as bacterial density after 7 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Nanomolar,634686,>,1,1,>,,MIC,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,128.0
52701,52701,,,1866461,[],CHEMBL920155,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as relative light unit after 11 days by LORA assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Nanomolar,634686,>,1,1,>,,MIC,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,128.0
52702,52702,,,1866490,[],CHEMBL920156,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as bacterial density after 10 days,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1145536,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Nanomolar,634686,>,1,1,>,,MIC,nM,,128000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC,uM,UO_0000065,,128.0
52703,52703,,,1868036,[],CHEMBL919822,Antibacterial activity against Bacteroides fragilis by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634860,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,ug ml-1,UO_0000274,,4.0
52704,52704,,,1868114,[],CHEMBL919822,Antibacterial activity against Bacteroides fragilis by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634860,=,1,1,=,,MIC50,ug.mL-1,,1.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC50,ug ml-1,UO_0000274,,1.0
52705,52705,,,1868128,[],CHEMBL919823,Antibacterial activity against Clostridium difficile by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634860,=,1,1,=,,MIC50,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC50,ug ml-1,UO_0000274,,2.0
52706,52706,,,1868129,[],CHEMBL919823,Antibacterial activity against Clostridium difficile by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634860,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC90,ug ml-1,UO_0000274,,32.0
52707,52707,,,1868175,[],CHEMBL916558,Antibacterial activity against Staphylococcus aureus LUG855 in Mueller-Hinton medium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
52708,52708,,,1868179,[],CHEMBL916559,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus HT20010734 in in Mueller-Hinton medium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
52709,52709,,,1868183,[],CHEMBL916560,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus HT20020488 in Mueller-Hinton medium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
52710,52710,,,1868187,[],CHEMBL916561,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus HT20030203 in Mueller-Hinton medium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
52711,52711,,,1868191,[],CHEMBL916562,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus HT20040332 in Mueller-Hinton medium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
52712,52712,,,1868195,[],CHEMBL915627,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus HT20041010 in Mueller-Hinton medium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
52713,52713,,,1868199,[],CHEMBL915628,Antibacterial activity against Staphylococcus aureus LUG855 in CCY media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
52714,52714,,,1868203,[],CHEMBL916563,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus HT20010734 in CCY medium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
52715,52715,,,1868207,[],CHEMBL916564,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus HT20020488 in CCY medium,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
52716,52716,,,1868211,[],CHEMBL916565,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus HT20030203 in CCY media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
52717,52717,,,1868215,[],CHEMBL916566,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus HT20040332 in CCY media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
52718,52718,,,1868219,[],CHEMBL916567,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus HT20041010 in CCY media,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634784,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
52719,52719,,Dose-dependent effect,1868262,[],CHEMBL916568,Decrease in Panton-Valentine leukocidin level in Staphylococcus aureus LUG855 in CCY medium,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,634784,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
52720,52720,,Dose-dependent effect,1868269,[],CHEMBL916569,Decrease in Panton-Valentine leukocidin level in community acquired methicillin-resistant Staphylococcus aureus HT20010734 in CYY medium,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,634784,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
52721,52721,,Dose-dependent effect,1868270,[],CHEMBL916570,Decrease in Panton-Valentine leukocidin level in community acquired methicillin-resistant Staphylococcus aureus HT20020488 in CYY medium,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,634784,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
52722,52722,,Dose-dependent effect,1868271,[],CHEMBL916571,Decrease in Panton-Valentine leukocidin level in community acquired methicillin-resistant Staphylococcus aureus HT20030203 in CYY medium,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,634784,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
52723,52723,,Dose-dependent effect,1868272,[],CHEMBL916572,Decrease in Panton-Valentine leukocidin level in community acquired methicillin-resistant Staphylococcus aureus HT20040332 in CYY medium,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,634784,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
52724,52724,,Dose-dependent effect,1868273,[],CHEMBL916573,Decrease in Panton-Valentine leukocidin level in community acquired methicillin-resistant Staphylococcus aureus HT20041010 in CYY medium,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147090,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,634784,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
52725,52725,,,1868280,[],CHEMBL919810,Antibacterial activity against Propionibacterium acnes,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634860,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC50,ug ml-1,UO_0000274,,0.06
52726,52726,,,1868281,[],CHEMBL919810,Antibacterial activity against Propionibacterium acnes,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634860,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC90,ug ml-1,UO_0000274,,0.06
52727,52727,,,1868286,[],CHEMBL919276,Antibacterial activity against Peptostreptococcus sp. by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634860,=,1,1,=,,MIC50,ug.mL-1,,0.25,CHEMBL614616,Peptostreptococcus sp.,Peptostreptococcus sp.,1262.0,,,MIC50,ug ml-1,UO_0000274,,0.25
52728,52728,,,1868287,[],CHEMBL919276,Antibacterial activity against Peptostreptococcus sp. by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1147099,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634860,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL614616,Peptostreptococcus sp.,Peptostreptococcus sp.,1262.0,,,MIC90,ug ml-1,UO_0000274,,1.0
52729,52729,,,1868400,[],CHEMBL920714,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634665,<=,1,1,<=,,MIC50,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.03
52730,52730,,,1868401,[],CHEMBL920714,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,634665,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,4.0
52731,52731,,,1868424,[],CHEMBL920715,Antimicrobial susceptibility of tetracycline-resistant Streptococcus pneumoniae from respiratory tract disease patient assessed as percent susceptible isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,634665,=,1,0,=,,Activity,%,,76.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,76.9
52732,52732,,,1868460,[],CHEMBL920716,Antimicrobial susceptibility of tetracycline-resistant Streptococcus pneumoniae from respiratory tract disease patient assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1145535,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,634665,=,1,0,=,,Activity,%,,23.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,23.1
52733,52733,,Not Active,1917546,[],CHEMBL894357,Antibacterial activity against multidrug resistant Staphylococcus aureus 49589,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1148734,J Med Chem,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,654124,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
52734,52734,,,2085134,[],CHEMBL929914,Inhibition of PAD4 by ABPP-based assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1143172,Bioorg Med Chem,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Nanomolar,698994,=,1,1,=,,IC50,nM,,5100000.0,CHEMBL6111,Homo sapiens,Protein-arginine deiminase type-4,9606.0,,,IC50,mM,UO_0000065,,5.1
52735,52735,,,2123034,[],CHEMBL936035,Antimicrobial activity against Bacteroides fragilis isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC,ug.mL-1,,1.89,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,1.89
52736,52736,,,2123035,[],CHEMBL936035,Antimicrobial activity against Bacteroides fragilis isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,ug ml-1,UO_0000274,,256.0
52737,52737,,,2123046,[],CHEMBL936957,Antimicrobial activity against Bacteroides distasonis isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC,ug.mL-1,,4.51,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC,ug ml-1,UO_0000274,,4.51
52738,52738,,,2123047,[],CHEMBL936957,Antimicrobial activity against Bacteroides distasonis isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,MIC90,ug ml-1,UO_0000274,,256.0
52739,52739,,,2123057,[],CHEMBL936958,Antimicrobial activity against Bacteroides ovatus isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC,ug.mL-1,,5.89,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC,ug ml-1,UO_0000274,,5.89
52740,52740,,,2123058,[],CHEMBL936958,Antimicrobial activity against Bacteroides ovatus isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,MIC90,ug ml-1,UO_0000274,,256.0
52741,52741,,,2123067,[],CHEMBL936959,Antimicrobial activity against Bacteroides thetaiotaomicron isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC,ug.mL-1,,6.62,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC,ug ml-1,UO_0000274,,6.62
52742,52742,,,2123068,[],CHEMBL936959,Antimicrobial activity against Bacteroides thetaiotaomicron isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,MIC90,ug ml-1,UO_0000274,,256.0
52743,52743,,,2123079,[],CHEMBL936960,Antimicrobial activity against Bacteroides uniformis isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC,ug.mL-1,,4.22,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,,MIC,ug ml-1,UO_0000274,,4.22
52744,52744,,,2123080,[],CHEMBL936960,Antimicrobial activity against Bacteroides uniformis isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,,MIC90,ug ml-1,UO_0000274,,256.0
52745,52745,,,2123091,[],CHEMBL936961,Antimicrobial activity against Bacteroides vulgatus isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC,ug.mL-1,,4.31,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC,ug ml-1,UO_0000274,,4.31
52746,52746,,,2123092,[],CHEMBL936961,Antimicrobial activity against Bacteroides vulgatus isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,MIC90,ug ml-1,UO_0000274,,256.0
52747,52747,,,2123103,[],CHEMBL936962,Antimicrobial activity against Bacteroides caccae isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC,ug.mL-1,,3.63,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,,MIC,ug ml-1,UO_0000274,,3.63
52748,52748,,,2123104,[],CHEMBL936962,Antimicrobial activity against Bacteroides caccae isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,,MIC90,ug ml-1,UO_0000274,,256.0
52749,52749,,,2123115,[],CHEMBL936963,Antimicrobial activity against Bacteroides eggerthii isolates by agar dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC,ug.mL-1,,3.63,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,3.63
52750,52750,,,2123116,[],CHEMBL936963,Antimicrobial activity against Bacteroides eggerthii isolates by agar dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,256.0
52751,52751,,,2123127,[],CHEMBL936964,Antimicrobial activity against Bacteroides stercoris isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC,ug.mL-1,,3.63,CHEMBL614750,Bacteroides stercoris,Bacteroides stercoris,46506.0,,,MIC,ug ml-1,UO_0000274,,3.63
52752,52752,,,2123128,[],CHEMBL936964,Antimicrobial activity against Bacteroides stercoris isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL614750,Bacteroides stercoris,Bacteroides stercoris,46506.0,,,MIC90,ug ml-1,UO_0000274,,256.0
52753,52753,,,2123139,[],CHEMBL936965,Antimicrobial activity against Bacteroides merdae isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC,ug.mL-1,,3.63,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,,MIC,ug ml-1,UO_0000274,,3.63
52754,52754,,,2123140,[],CHEMBL936965,Antimicrobial activity against Bacteroides merdae isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,702851,=,1,1,=,,MIC90,ug.mL-1,,256.0,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,,MIC90,ug ml-1,UO_0000274,,256.0
52755,52755,,,2123149,[],CHEMBL936966,Antimicrobial activity against Bacteroides fragilis assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,702851,=,1,0,=,,Activity,%,,19.3,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,Activity,%,UO_0000187,,19.3
52756,52756,,,2123155,[],CHEMBL936967,Antimicrobial activity against Bacteroides distasonis assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,702851,=,1,0,=,,Activity,%,,29.6,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,,Activity,%,UO_0000187,,29.6
52757,52757,,,2123161,[],CHEMBL936968,Antimicrobial activity against Bacteroides ovatus assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,702851,=,1,0,=,,Activity,%,,33.4,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,,Activity,%,UO_0000187,,33.4
52758,52758,,,2123166,[],CHEMBL936969,Antimicrobial activity against Bacteroides thetaiotaomicron assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,702851,=,1,0,=,,Activity,%,,33.3,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,,Activity,%,UO_0000187,,33.3
52759,52759,,,2123172,[],CHEMBL936970,Antimicrobial activity against Bacteroides uniformis assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,702851,=,1,0,=,,Activity,%,,28.9,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,,Activity,%,UO_0000187,,28.9
52760,52760,,,2123178,[],CHEMBL936971,Antimicrobial activity against Bacteroides vulgatus assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,702851,=,1,0,=,,Activity,%,,35.3,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,,Activity,%,UO_0000187,,35.3
52761,52761,,,2123184,[],CHEMBL936972,Antimicrobial activity against Bacteroides caccae assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,702851,=,1,0,=,,Activity,%,,28.2,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,,Activity,%,UO_0000187,,28.2
52762,52762,,,2123190,[],CHEMBL936973,Antimicrobial activity against Bacteroides eggerthii assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,702851,=,1,0,=,,Activity,%,,28.2,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Activity,%,UO_0000187,,28.2
52763,52763,,,2123196,[],CHEMBL936974,Antimicrobial activity against Bacteroides merdae assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,702851,=,1,0,=,,Activity,%,,28.2,CHEMBL615057,Parabacteroides merdae,Parabacteroides merdae,46503.0,,,Activity,%,UO_0000187,,28.2
52764,52764,,,2123202,[],CHEMBL936034,Antimicrobial activity against Bacteroides stercoris assessed as percent resistant isolates,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143824,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,702851,=,1,0,=,,Activity,%,,28.2,CHEMBL614750,Bacteroides stercoris,Bacteroides stercoris,46506.0,,,Activity,%,UO_0000187,,28.2
52765,52765,,,2127054,[],CHEMBL935917,Antibacterial activity against drug-resistant Propionibacterium acnes SW10 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.125
52766,52766,,,2127056,[],CHEMBL935918,Antibacterial activity against drug-resistant Propionibacterium acnes SW16 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.06
52767,52767,,,2127058,[],CHEMBL935919,Antibacterial activity against drug-resistant Propionibacterium acnes SW17 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.06
52768,52768,,,2127062,[],CHEMBL935920,Antibacterial activity against drug-resistant Propionibacterium acnes SW26 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.06
52769,52769,,,2127065,[],CHEMBL935921,Antibacterial activity against drug-resistant Propionibacterium acnes D-04/97 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.125
52770,52770,,,2127069,[],CHEMBL935922,Antibacterial activity against drug-resistant Propionibacterium acnes OK8/97 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.125
52771,52771,,,2127073,[],CHEMBL935923,Antibacterial activity against drug-resistant Propionibacterium acnes EG7NS after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.06
52772,52772,,,2127078,[],CHEMBL935924,Antibacterial activity against drug-resistant Propionibacterium acnes EG13NS after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.06
52773,52773,,,2127082,[],CHEMBL935925,Antibacterial activity against drug-resistant Propionibacterium granulosum NCTC-11865 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.06
52774,52774,,,2127086,[],CHEMBL935926,Antibacterial activity against drug-resistant Propionibacterium acnes SW11 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.5
52775,52775,,,2127090,[],CHEMBL935927,Antibacterial activity against drug-resistant Propionibacterium acnes EG3NS after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.25
52776,52776,,,2127095,[],CHEMBL935928,Antibacterial activity against drug-resistant Propionibacterium acnes SW3CD after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,8.0
52777,52777,,,2127098,[],CHEMBL935929,Antibacterial activity against drug-resistant Propionibacterium acnes P95 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.5
52778,52778,,,2127102,[],CHEMBL936903,Antibacterial activity against drug-resistant Propionibacterium acnes P401:5 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,1.0
52779,52779,,,2127106,[],CHEMBL936904,Antibacterial activity against drug-resistant Propionibacterium acnes P425:1 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,512.0
52780,52780,,,2127110,[],CHEMBL936905,Antibacterial activity against drug-resistant Propionibacterium acnes P429:1 (SC) after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,4.0
52781,52781,,,2127114,[],CHEMBL936906,Antibacterial activity against drug-resistant Propionibacterium acnes P429:1 (BC) after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,8.0
52782,52782,,,2127118,[],CHEMBL936907,Antibacterial activity against drug-resistant Propionibacterium acnes SW54EA after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,32.0
52783,52783,,,2127122,[],CHEMBL936908,Antibacterial activity against drug-resistant Propionibacterium acnes SW101T after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,256.0
52784,52784,,,2127125,[],CHEMBL936909,Antibacterial activity against drug-resistant Propionibacterium acnes GE46EB after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,512.0
52785,52785,,,2127127,[],CHEMBL936004,Antibacterial activity against drug-resistant Propionibacterium acnes FG7E after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,>=,1,1,>=,,MIC,ug.mL-1,,32.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,32.0
52786,52786,,,2127131,[],CHEMBL936005,Antibacterial activity against drug-resistant Propionibacterium acnes GE4E after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,512.0
52787,52787,,,2127135,[],CHEMBL936006,Antibacterial activity against drug-resistant Propionibacterium acnes SP64E after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,512.0
52788,52788,,,2127139,[],CHEMBL936007,Antibacterial activity against drug-resistant Propionibacterium acnes SW101CDA after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,>=,1,1,>=,,MIC,ug.mL-1,,512.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,512.0
52789,52789,,,2127143,[],CHEMBL936008,Antibacterial activity against drug-resistant Propionibacterium acnes P:413 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,<=,1,1,<=,,MIC,ug.mL-1,,0.06,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,0.06
52790,52790,,,2127147,[],CHEMBL936009,Antibacterial activity against drug-resistant Propionibacterium acnes QK6/92 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,1.0
52791,52791,,,2127151,[],CHEMBL936010,Antibacterial activity against drug-resistant Propionibacterium acnes P322:2 after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC,ug ml-1,UO_0000274,,4.0
52792,52792,,,2127155,[],CHEMBL936011,Antibacterial activity against drug-resistant Propionibacterium acnes EG7NS after 72 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,>,1,0,>,,MBC,ug ml-1,,32.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MBC,ug ml-1,UO_0000274,,32.0
52793,52793,,,2127159,[],CHEMBL936012,Antibacterial activity against drug-resistant Propionibacterium acnes SW3CD after 72 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,>,1,0,>,,MBC,ug ml-1,,32.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MBC,ug ml-1,UO_0000274,,32.0
52794,52794,,,2127163,[],CHEMBL936013,Antibacterial activity against drug-resistant Propionibacterium acnes P95 after 72 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,0,=,,MBC,ug ml-1,,32.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MBC,ug ml-1,UO_0000274,,32.0
52795,52795,,,2127174,[],CHEMBL936016,MBC/MIC ratio of Propionibacterium acnes EG7NS,F,,,BAO_0000193,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,703076,>=,1,0,>=,,Ratio,,,533.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,Ratio,,,,533.0
52796,52796,,,2127175,[],CHEMBL936017,MBC/MIC ratio of Propionibacterium acnes SW3CD,F,,,BAO_0000193,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,703076,>,1,0,>,,Ratio,,,4.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,Ratio,,,,4.0
52797,52797,,,2127176,[],CHEMBL936018,MBC/MIC ratio of Propionibacterium acnes P95,F,,,BAO_0000193,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,703076,>,1,0,>,,Ratio,,,64.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,Ratio,,,,64.0
52798,52798,,,2127177,[],CHEMBL936019,MBC/MIC ratio of Propionibacterium acnes SW101T,F,,,BAO_0000193,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,703076,>,1,0,>,,Ratio,,,2.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,Ratio,,,,2.0
52799,52799,,,2127185,[],CHEMBL936021,Antibacterial activity against Corynebacterium jeikeium after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,7.97,CHEMBL613351,Corynebacterium jeikeium,Corynebacterium jeikeium,38289.0,,,MIC,ug ml-1,UO_0000274,,7.97
52800,52800,,,2127188,[],CHEMBL936022,Antibacterial activity against Corynebacterium diphtheriae after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,7.97,CHEMBL612638,Corynebacterium diphtheriae,Corynebacterium diphtheriae,1717.0,,,MIC,ug ml-1,UO_0000274,,7.97
52801,52801,,,2127191,[],CHEMBL936023,Antibacterial activity against Corynebacterium amycolatum after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,7.97,CHEMBL615030,Corynebacterium amycolatum,Corynebacterium amycolatum,43765.0,,,MIC,ug ml-1,UO_0000274,,7.97
52802,52802,,,2127194,[],CHEMBL936024,Antibacterial activity against Corynebacterium minutissimum after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,7.97,CHEMBL613954,Corynebacterium minutissimum,Corynebacterium minutissimum,38301.0,,,MIC,ug ml-1,UO_0000274,,7.97
52803,52803,,,2127198,[],CHEMBL936025,Antibacterial activity against Staphylococcus epidermidis after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,1.12,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.12
52804,52804,,,2127204,[],CHEMBL936026,Antibacterial activity against methicillin-susceptible Staphylococcus aureus after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,1.16,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.16
52805,52805,,,2127207,[],CHEMBL937029,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,1.16,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.16
52806,52806,,,2127210,[],CHEMBL937030,Antibacterial activity against borderline oxacillin-resistant Staphylococcus aureus after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,1.16,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.16
52807,52807,,,2127214,[],CHEMBL936100,Antibacterial activity against Streptococcus pyogenes after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,0.07,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.07
52808,52808,,,2127219,[],CHEMBL936098,Antibacterial activity against Streptococcus dysgalactiae subsp. dysgalactiae after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,0.11,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug ml-1,UO_0000274,,0.11
52809,52809,,,2127222,[],CHEMBL936099,Antibacterial activity against Streptococcus equi subsp. zooepidemicus after 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143835,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703076,=,1,1,=,,MIC,ug.mL-1,,0.11,CHEMBL612697,Streptococcus equi subsp. zooepidemicus,Streptococcus equi subsp. zooepidemicus,40041.0,,,MIC,ug ml-1,UO_0000274,,0.11
52810,52810,,,2127574,[],CHEMBL938262,Antibacterial activity against Peptostreptococcus anaerobius,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703546,=,1,1,=,,MIC50,ug.mL-1,,0.19,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC50,ug ml-1,UO_0000274,,0.19
52811,52811,,,2127575,[],CHEMBL938262,Antibacterial activity against Peptostreptococcus anaerobius,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703546,=,1,1,=,,MIC90,ug.mL-1,,0.75,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,,MIC90,ug ml-1,UO_0000274,,0.75
52812,52812,,,2127586,[],CHEMBL938263,Antibacterial activity against Peptostreptococcus stomatis,F,,,BAO_0000179,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703546,=,1,1,=,,MIC90,ug.mL-1,,0.016,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug ml-1,UO_0000274,,0.016
52813,52813,,,2127587,[],CHEMBL938263,Antibacterial activity against Peptostreptococcus stomatis,F,,,BAO_0003035,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1143851,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,703546,<,1,1,<,,MIC50,ug.mL-1,,0.016,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug ml-1,UO_0000274,,0.016
52814,52814,,,2158874,[],CHEMBL935596,Antibacterial activity against Streptococcus pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1144730,Bioorg Med Chem Lett,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,707340,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
52815,52815,,,2158875,[],CHEMBL935598,Antibacterial activity against Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1144730,Bioorg Med Chem Lett,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,707340,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.125
52816,52816,,,2158876,[],CHEMBL935597,"Antibacterial activity against macrolide, licosamide and streptogramin resistant Staphylococcus aureus by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1144730,Bioorg Med Chem Lett,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,707340,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
52817,52817,,,2158877,[],CHEMBL935600,Antibacterial activity against Enterococcus faecium by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1144730,Bioorg Med Chem Lett,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,707340,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,0.125
52818,52818,,,2158878,[],CHEMBL935601,Antibacterial activity against Enterococcus faecalis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1144730,Bioorg Med Chem Lett,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,707340,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.25
52819,52819,,,2158879,[],CHEMBL935603,Antibacterial activity against Bacteroides fragilis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1144730,Bioorg Med Chem Lett,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,707340,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC,ug ml-1,UO_0000274,,0.06
52820,52820,,,2158880,[],CHEMBL935604,Inhibition of protein synthesis in Escherichia coli by transcription/translation inhibition assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1144730,Bioorg Med Chem Lett,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,707340,=,1,1,=,,MIC,ug.mL-1,,2.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.7
52821,52821,,,2158965,[],CHEMBL935602,Antibacterial activity against Staphylococcus aureus Smith infected iv dosed mouse septicemia model,F,,,BAO_0003036,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1144730,Bioorg Med Chem Lett,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,707340,=,1,1,=,,ED50,mg.kg-1,,2.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,2.8
52822,52822,,,2158966,[],CHEMBL935599,Antibacterial activity against Staphylococcus aureus Smith infected po dosed mouse septicemia model,F,,,BAO_0003036,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1144730,Bioorg Med Chem Lett,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,707340,=,1,1,=,,ED50,mg.kg-1,,19.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,19.9
52823,52823,,,2199092,[],CHEMBL996027,Growth inhibition as apicoplast copy number of Plasmodium falciparum FCK2 at 100 nM by [3H]hypoxanthine uptake,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1156431,J Biol Chem,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,764580,=,1,0,=,,Activity,,,0.4,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,0.4
52824,52824,,Active,2199097,[],CHEMBL996029,TufA expression level in Plasmodium falciparum FCK2 first asexual cycle,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1156431,J Biol Chem,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,764580,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
52825,52825,,,2353137,[],CHEMBL965261,Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB10 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150781,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794422,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL613153,Streptococcus pasteurianus,Streptococcus pasteurianus,197614.0,,,MIC,ug ml-1,UO_0000274,,256.0
52826,52826,,,2353138,[],CHEMBL965262,Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB28 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150781,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794422,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613153,Streptococcus pasteurianus,Streptococcus pasteurianus,197614.0,,,MIC,ug ml-1,UO_0000274,,16.0
52827,52827,,,2353139,[],CHEMBL965263,Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB30 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150781,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794422,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL613153,Streptococcus pasteurianus,Streptococcus pasteurianus,197614.0,,,MIC,ug ml-1,UO_0000274,,0.5
52828,52828,,,2353140,[],CHEMBL965264,Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB33 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150781,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794422,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL613153,Streptococcus pasteurianus,Streptococcus pasteurianus,197614.0,,,MIC,ug ml-1,UO_0000274,,512.0
52829,52829,,,2353141,[],CHEMBL965265,Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB34 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150781,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794422,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL613153,Streptococcus pasteurianus,Streptococcus pasteurianus,197614.0,,,MIC,ug ml-1,UO_0000274,,128.0
52830,52830,,,2353142,[],CHEMBL965266,Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB40 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150781,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794422,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL613153,Streptococcus pasteurianus,Streptococcus pasteurianus,197614.0,,,MIC,ug ml-1,UO_0000274,,512.0
52831,52831,,,2353143,[],CHEMBL965267,Antibacterial activity against high-level gentamicin resistant Streptococcus pasteurianus SB41 isolate carrying transposon-borne resistance gene [aac(6')Ie-aph(2'')Ia] by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150781,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794422,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL613153,Streptococcus pasteurianus,Streptococcus pasteurianus,197614.0,,,MIC,ug ml-1,UO_0000274,,512.0
52832,52832,,,2353144,[],CHEMBL965268,Antimicrobial activity against Enterococcus faecalis ATCC 29212 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150781,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794422,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
52833,52833,,,2353145,[],CHEMBL965269,Antibacterial activity against Streptococcus bovis ATCC 33317 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150781,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,794422,<,1,1,<,,MIC,ug.mL-1,,0.03,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,,MIC,ug ml-1,UO_0000274,,0.03
52834,52834,,,2353285,[],CHEMBL966106,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793426,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,128.0
52835,52835,,,2353286,[],CHEMBL966106,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793426,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,128.0
52836,52836,,,2353301,[],CHEMBL966107,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate by CLSI dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793426,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,ug ml-1,UO_0000274,,0.12
52837,52837,,,2353302,[],CHEMBL966107,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate by CLSI dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793426,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,0.12
52838,52838,,,2353317,[],CHEMBL966108,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sp. by CLSI dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793426,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC50,ug ml-1,UO_0000274,,128.0
52839,52839,,,2353318,[],CHEMBL966108,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sp. by CLSI dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793426,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC90,ug ml-1,UO_0000274,,128.0
52840,52840,,,2353333,[],CHEMBL966109,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. by CLSI dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793426,=,1,1,=,,MIC50,ug.mL-1,,0.12,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC50,ug ml-1,UO_0000274,,0.12
52841,52841,,,2353334,[],CHEMBL966109,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. by CLSI dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,793426,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,MIC90,ug ml-1,UO_0000274,,0.25
52842,52842,,,2353373,[],CHEMBL956442,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate assessed as percent susceptible isolates by CLSI dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,793426,=,1,0,=,,Activity,%,,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,12.0
52843,52843,,,2353380,[],CHEMBL954856,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate assessed as percent resistant isolates by CLSI dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,793426,=,1,0,=,,Activity,%,,88.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,88.0
52844,52844,,,2353391,[],CHEMBL954857,Antibacterial activity against methicillin-susceptible Staphylococcus aureus isolate assessed as susceptible resistant isolates by CLSI dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,793426,=,1,0,=,,Activity,%,,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,100.0
52845,52845,,,2353398,[],CHEMBL954858,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate assessed as percent resistant isolates by CLSI dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,793426,=,1,0,=,,Activity,%,,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,0.0
52846,52846,,,2353404,[],CHEMBL954859,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. assessed as percent susceptible isolates by CLSI dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,793426,=,1,0,=,,Activity,%,,44.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,Activity,%,UO_0000187,,44.0
52847,52847,,,2353411,[],CHEMBL955595,Antibacterial activity against methicillin-resistant coagulase-negative Staphylococcus sp. assessed as percent resistant isolates by CLSI dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,793426,=,1,0,=,,Activity,%,,54.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,Activity,%,UO_0000187,,54.0
52848,52848,,,2353412,[],CHEMBL955596,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. assessed as percent susceptible isolates by CLSI dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,793426,=,1,0,=,,Activity,%,,97.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,Activity,%,UO_0000187,,97.0
52849,52849,,,2353419,[],CHEMBL955597,Antibacterial activity against methicillin-susceptible coagulase-negative Staphylococcus sp. assessed as percent resistant isolates by CLSI dilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1150783,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,793426,=,1,0,=,,Activity,%,,3.0,CHEMBL612243,Staphylococcus sp.,Staphylococcus sp.,29387.0,,,Activity,%,UO_0000187,,3.0
52850,52850,,,2364290,[],CHEMBL993349,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells at 100 uM by confocal microscopy,B,,,BAO_0000201,BAO_0000219,cell-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1140113,J Med Chem,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,746127,=,1,1,=,,Inhibition,%,,19.5,CHEMBL5685,Homo sapiens,Solute carrier family 22 member 1,9606.0,,,INH,%,UO_0000187,,19.5
52851,52851,,,2495046,[],CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779487,>,1,1,>,,MIC50,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,0.5
52852,52852,,,2495047,[],CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779487,>,1,1,>,,MIC90,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,0.5
52853,52853,,,2495051,[],CHEMBL1028013,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,779487,=,1,0,=,,Activity,%,,87.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,%,UO_0000187,,87.2
52854,52854,,,2495075,[],CHEMBL1028014,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent resistant isolates by CLSI breakpoint method,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779487,>=,1,0,>=,,Activity,ug ml-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,1.0
52855,52855,,,2495085,[],CHEMBL1028015,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae assessed as percent sensitive isolates by CLSI breakpoint method,F,,,BAO_0000181,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779487,<=,1,0,<=,,Activity,ug ml-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,Activity,ug ml-1,UO_0000274,,0.25
52856,52856,,,2495100,[],CHEMBL1028012,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779487,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
52857,52857,,,2495105,[],CHEMBL1028016,Antibacterial activity against constitutive macrolide-lincosamide-streptogramin B-resistant Streptococcus pneumoniae isolates by double-disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779487,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
52858,52858,,,2495106,[],CHEMBL1028017,Antibacterial activity against inducible macrolide-lincosamide-streptogramin B-resistant Streptococcus pneumoniae isolates by double-disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779487,>,1,1,>,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
52859,52859,,,2495107,[],CHEMBL1028018,Antibacterial activity against macrolide-resistant Streptococcus pneumoniae isolates by double-disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154403,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779487,<=,1,1,<=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52860,52860,,,2496170,[],CHEMBL983320,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
52861,52861,,,2496180,[],CHEMBL983321,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
52862,52862,,,2496190,[],CHEMBL983322,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,mg/L,UO_0000274,,0.5
52863,52863,,,2496200,[],CHEMBL983323,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC,mg/L,UO_0000274,,0.5
52864,52864,,,2496233,[],CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.03
52865,52865,,,2496244,[],CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.03
52866,52866,,,2496255,[],CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,>=,1,1,>=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.06
52867,52867,,,2496266,[],CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC,mg/L,UO_0000274,,0.03
52868,52868,,,2496277,[],CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC,mg/L,UO_0000274,,0.03
52869,52869,,,2497053,[],CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC,ug.mL-1,,0.03,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC,mg/L,UO_0000274,,0.03
52870,52870,,,2497067,[],CHEMBL983320,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/L,UO_0000274,,0.5
52871,52871,,,2497077,[],CHEMBL983321,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC50,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC50,mg/L,UO_0000274,,0.5
52872,52872,,,2497087,[],CHEMBL983322,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC50,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,mg/L,UO_0000274,,0.5
52873,52873,,,2497097,[],CHEMBL983323,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC50,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC50,mg/L,UO_0000274,,0.5
52874,52874,,,2497130,[],CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,mg/L,UO_0000274,,0.06
52875,52875,,,2497141,[],CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,mg/L,UO_0000274,,0.06
52876,52876,,,2497152,[],CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,>,1,1,>,,MIC50,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,mg/L,UO_0000274,,0.25
52877,52877,,,2497163,[],CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC50,ug.mL-1,,0.03,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC50,mg/L,UO_0000274,,0.03
52878,52878,,,2497174,[],CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,=,1,1,=,,MIC50,ug.mL-1,,0.06,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC50,mg/L,UO_0000274,,0.06
52879,52879,,,2497185,[],CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC50,ug.mL-1,,0.03,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC50,mg/L,UO_0000274,,0.03
52880,52880,,,2497197,[],CHEMBL983320,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC90,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,0.5
52881,52881,,,2497207,[],CHEMBL983321,Antimicrobial activity against methicillin-resistant Staphylococcus aureus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,4.0
52882,52882,,,2497217,[],CHEMBL983322,Antimicrobial activity against methicillin-susceptible coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,<=,1,1,<=,,MIC90,ug.mL-1,,0.5,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,mg/L,UO_0000274,,0.5
52883,52883,,,2497227,[],CHEMBL983323,Antimicrobial activity against methicillin-resistant coagulase-negative Staphylococcus after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,>,1,1,>,,MIC90,ug.mL-1,,4.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,,MIC90,mg/L,UO_0000274,,4.0
52884,52884,,,2497260,[],CHEMBL983328,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,mg/L,UO_0000274,,0.06
52885,52885,,,2497271,[],CHEMBL986009,Antibacterial activity against penicillin-intermediate Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,>,1,1,>,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,mg/L,UO_0000274,,0.25
52886,52886,,,2497282,[],CHEMBL986010,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,>,1,1,>,,MIC90,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,mg/L,UO_0000274,,0.25
52887,52887,,,2497293,[],CHEMBL986011,Antimicrobial activity against Streptococcus group A after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,,MIC90,mg/L,UO_0000274,,0.06
52888,52888,,,2497304,[],CHEMBL986012,Antimicrobial activity against Streptococcus group B after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,,MIC90,mg/L,UO_0000274,,0.06
52889,52889,,,2497315,[],CHEMBL986013,Antimicrobial activity against Streptococcus viridans after 20 to 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154412,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,780052,>,1,1,>,,MIC90,ug.mL-1,,0.25,CHEMBL612332,Streptococcus viridans,Streptococcus viridans,78535.0,,,MIC90,mg/L,UO_0000274,,0.25
52890,52890,,,2500190,[],CHEMBL1019518,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779970,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.0
52891,52891,,,2500202,[],CHEMBL1019517,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779970,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,2.0
52892,52892,,,2500207,[],CHEMBL1019520,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pACYC184 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779970,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,4.0
52893,52893,,,2500212,[],CHEMBL1019516,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779970,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,6.0
52894,52894,,,2500254,[],CHEMBL1019521,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP3 plasmid containing Enterobacter aerogenes acrR gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779970,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,32.0
52895,52895,,,2500374,[],CHEMBL1019515,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779970,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,256.0
52896,52896,,,2500375,[],CHEMBL1019519,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP2 plasmid containing Enterobacter cloacae acrA gene by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779970,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,256.0
52897,52897,,,2500376,[],CHEMBL1019522,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pBGS18 plasmid by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1154428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,779970,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,256.0
52898,52898,,,2537144,[],CHEMBL973913,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1157314,J Nat Prod,2006.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,759871,>,1,1,>,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
52899,52899,,,2537153,[],CHEMBL973914,Antibacterial activity against methicillin-resistant Staphylococcus aureus 78-13607A after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1157314,J Nat Prod,2006.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,759871,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
52900,52900,,Active,2556445,[],CHEMBL994445,"Inhibition of clindamycin-susceptible nonepidemic Clostridium difficile strain6 in CF1 mouse at 0.2 mg/day, sc for 5 days",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52901,52901,,Active,2556454,[],CHEMBL994444,"Inhibition of clindamycin-susceptible epidemic Clostridium difficile NAP1 in CF1 mouse at 0.2 mg/day, sc for 5 days",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52902,52902,,,2556466,[],CHEMBL990922,Antimicrobial activity against nonepidemic Clostridium difficile ATCC 9689 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743734,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,256.0
52903,52903,,,2556471,[],CHEMBL990923,Antimicrobial activity against nonepidemic Clostridium difficile J29 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743734,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,256.0
52904,52904,,,2556476,[],CHEMBL990924,Antimicrobial activity against epidemic Clostridium difficile BI9 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743734,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,256.0
52905,52905,,,2556481,[],CHEMBL990925,Antimicrobial activity against epidemic Clostridium difficile BI6-8-17 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743734,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,256.0
52906,52906,,,2556486,[],CHEMBL990926,Antimicrobial activity against fluoroquinolone-resistant epidemic Clostridium difficile NAP1 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743734,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
52907,52907,,,2556491,[],CHEMBL990927,Antimicrobial activity against fluoroquinolone-susceptible nonepidemic Clostridium difficile strain6 by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,743734,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,MIC,ug ml-1,UO_0000274,,2.0
52908,52908,,Active,2556535,[],CHEMBL994418,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52909,52909,,Active,2556536,[],CHEMBL994419,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52910,52910,,Active,2556537,[],CHEMBL994420,"Effect on growth of epidemic Clostridium difficile BI9 in CF1 mouse assessed as increase in bacterial density in cecal content at 2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52911,52911,,Active,2556538,[],CHEMBL994421,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52912,52912,,Active,2556539,[],CHEMBL994422,"Effect on growth of nonepidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52913,52913,,Active,2556540,[],CHEMBL994423,"Effect on growth of nonepidemic Clostridium difficile J29 in CF1 mouse assessed as increase in bacterial density in cecal content at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52914,52914,,Active,2556541,[],CHEMBL994424,"Effect on growth of epidemic Clostridium difficile BI9 in CF1 mouse assessed as increase in bacterial density in cecal content at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52915,52915,,Active,2556542,[],CHEMBL994425,"Effect on growth of epidemic Clostridium difficile BI6-8-17 in CF1 mouse assessed as increase in bacterial density in cecal content at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52916,52916,,Not Active,2556558,[],CHEMBL993695,Effect on growth of fluoroquinolone-susceptible epidemic Clostridium difficile ATCC 9689 in CF1 mouse assessed as increase in bacterial density in cecal content dosed sc for 5 days,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52917,52917,,Not Active,2556559,[],CHEMBL994447,"Inhibition of clindamycin-susceptible nonepidemic Clostridium difficile strain6 in CF1 mouse at 0.2 mg/day, sc for 5 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52918,52918,,Active,2556560,[],CHEMBL994426,"Increase in toxin level in nonepidemic Clostridium difficile ATCC 9689 infected in CF1 mouse at 2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52919,52919,,Active,2556563,[],CHEMBL994427,"Increase in toxin level in nonepidemic Clostridium difficile J29 infected CF1 mouse at 2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52920,52920,,Active,2556564,[],CHEMBL994428,"Increase in toxin level in epidemic Clostridium difficile BI9 infected CF1 mouse at 2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52921,52921,,Active,2556568,[],CHEMBL994430,"Increase in toxin level in nonepidemic Clostridium difficile ATCC 9689 infected in CF1 mouse at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52922,52922,,Active,2556569,[],CHEMBL994431,"Increase in toxin level in nonepidemic Clostridium difficile J29 infected CF1 mouse at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52923,52923,,Active,2556571,[],CHEMBL994432,"Increase in toxin level in epidemic Clostridium difficile BI9 infected CF1 mouse at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52924,52924,,Active,2556573,[],CHEMBL990955,"Increase in toxin level in epidemic Clostridium difficile BI6-8-17 infected CF1 mouse at 1.4 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52925,52925,,Active,2556575,[],CHEMBL993681,"Increase in toxin level in nonepidemic Clostridium difficile ATCC 9689 infected in CF1 mouse at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52926,52926,,Active,2556577,[],CHEMBL993682,"Increase in toxin level in nonepidemic Clostridium difficile J29 infected CF1 mouse at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52927,52927,,Active,2556579,[],CHEMBL993683,"Increase in toxin level in epidemic Clostridium difficile BI9 infected CF1 mouse at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52928,52928,,Active,2556581,[],CHEMBL993684,"Increase in toxin level in epidemic Clostridium difficile BI6-8-17 infected CF1 mouse at 0.2 mg/day, sc for 4 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52929,52929,,Not Active,2556586,[],CHEMBL994446,"Inhibition of clindamycin-susceptible epidemic Clostridium difficile NAP1 in CF1 mouse at 0.2 mg/day, sc for 5 days assessed after 2 days of last treatment",F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1155776,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,743734,,1,0,,,Activity,,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,,Activity,,,,
52930,52930,,Not Active,2589893,[],CHEMBL965578,Inhibition of mouse brain MAOA,B,,,BAO_0000375,BAO_0000019,assay format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1152129,J Med Chem,2008.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,726108,,1,0,,,Activity,,,,CHEMBL3681,Mus musculus,Monoamine oxidase A,10090.0,,,Activity,,,,
52931,52931,,,2628550,[],CHEMBL945686,Antimalarial activity as 2nd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs by flow cytometry,F,,,BAO_0000190,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Nanomolar,792060,>,1,1,>,,IC50,nM,,100000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,100.0
52932,52932,,,2628556,[],CHEMBL945687,Antimalarial activity as 3rd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs dose then 48 hrs drug-free,F,,,BAO_0000190,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,8.05,0,http://www.openphacts.org/units/Nanomolar,792060,=,1,1,=,,IC50,nM,,8.81,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,0.00881
52933,52933,,,2628562,[],CHEMBL945688,Antimalarial activity as 2nd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by flow cytometry,F,,,BAO_0000190,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/Nanomolar,792060,>,1,1,>,,IC50,nM,,100000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,100.0
52934,52934,,,2628568,[],CHEMBL945689,Antimalarial activity as 3rd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs dose then 48 hrs drug-free,F,,,BAO_0000190,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,8.51,0,http://www.openphacts.org/units/Nanomolar,792060,=,1,1,=,,IC50,nM,,3.12,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,0.00312
52935,52935,,Not Active,2628588,[],CHEMBL948848,Antimalarial activity as arrested schizont maturation in chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 48 hrs at 25 nM dosed 96 hrs post infection,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,792060,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
52936,52936,,,2628610,[],CHEMBL952729,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 25 nM dosed 0-12 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,87.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,87.0
52937,52937,,,2628611,[],CHEMBL952730,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 25 nM dosed 0-24 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,49.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,49.0
52938,52938,,,2628612,[],CHEMBL952731,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 25 nM dosed 0-36 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,21.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,21.0
52939,52939,,,2628613,[],CHEMBL952732,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 25 nM dosed 0-48 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,11.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,11.0
52940,52940,,,2628614,[],CHEMBL952733,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 25 nM dosed 12-24 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,41.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,41.0
52941,52941,,,2628615,[],CHEMBL952734,Antimalarial activity as3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96 hrs at 25 nM dosed 12-36 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,15.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,15.0
52942,52942,,,2628616,[],CHEMBL952735,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 25 nM dosed 12-48 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,19.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,19.0
52943,52943,,,2628617,[],CHEMBL952736,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 25 nM dosed 24-36 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,52.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,52.0
52944,52944,,,2628618,[],CHEMBL938105,Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96 hr at 25 nM dosed 24-48 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,78.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,78.0
52945,52945,,,2628619,[],CHEMBL938106,Antimalarial activity as 3rd generation parasitaemia after 96 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes at 25 nM 36-48 hrs post invasion,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,63.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,63.0
52946,52946,,Active,2628642,[],CHEMBL948854,Antimalarial activity as segregation of apicoplast in chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 schizont infected human erythrocytes at 25 nM dosed 96 hrs post infection,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,792060,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
52947,52947,,Active,2628643,[],CHEMBL945692,Antimalarial activity as segregation of apicoplasts against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes at 25 nM 96 hrs post infection,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,792060,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
52948,52948,,,2628650,[],CHEMBL948853,Antimalarial activity as parasitaemia against chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,99.3,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,99.3
52949,52949,,,2628654,[],CHEMBL948852,Antimalarial activity as abnormal apicoplast morphology in chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,792060,=,1,0,=,,Activity,%,,85.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,%,UO_0000187,,85.2
52950,52950,,Active,2628656,[],CHEMBL948870,Antimalarial activity as abnormal apicoplast morphology in chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 after 48 hrs at 2xIC50 dosed 96 hrs post infection,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,792060,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
52951,52951,,Active,2628657,[],CHEMBL948871,Antimalarial activity in chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 after 48 hrs at 2xIC50 dosed 96 hrs post infection,F,,,BAO_0000375,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137635,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,,792060,,1,0,,,Activity,,,,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,Activity,,,,
52952,52952,,,2634658,[],CHEMBL1008425,Antimicrobial activity against mupirocin-susceptible methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783586,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
52953,52953,,,2634667,[],CHEMBL1008426,Antimicrobial activity against mupirocin-resistant methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783586,>,1,1,>,,MIC90,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,ug ml-1,UO_0000274,,8.0
52954,52954,,,2634676,[],CHEMBL1008427,Antimicrobial activity against mupirocin-susceptible methicillin-resistant Staphylococcus aureus assessed as resistant rate by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,783586,=,1,0,=,,Activity,%,,86.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,86.0
52955,52955,,,2634685,[],CHEMBL1008428,Antimicrobial activity against mupirocin-resistant methicillin-resistant Staphylococcus aureus assessed as resistant rate by broth microdilution method,F,,,BAO_0001103,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,783586,=,1,0,=,,Activity,%,,85.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,%,UO_0000187,,85.0
52956,52956,,,2634694,[],CHEMBL1008425,Antimicrobial activity against mupirocin-susceptible methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783586,<=,1,1,<=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
52957,52957,,,2634703,[],CHEMBL1008426,Antimicrobial activity against mupirocin-resistant methicillin-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1137649,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,783586,>=,1,1,>=,,MIC,ug.mL-1,,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,512.0
52958,52958,,,2659320,[],CHEMBL1026165,Antimicrobial activity against Balamuthia mandrillaris ATCC 50209 infected in HBMEC assessed as inhibition of encystment at 5 ug/mL after 7 days,F,,,BAO_0000201,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151422,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,817752,=,1,1,=,,Inhibition,%,,4.0,CHEMBL614751,Balamuthia mandrillaris,Balamuthia mandrillaris,66527.0,,,INH,%,UO_0000187,,4.0
52959,52959,,,2659321,[],CHEMBL1026166,Antimicrobial activity against Balamuthia mandrillaris ATCC 50209 infected in HBMEC assessed as inhibition of encystment at 10 ug/mL after 7 days,F,,,BAO_0000201,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151422,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,817752,=,1,1,=,,Inhibition,%,,0.0,CHEMBL614751,Balamuthia mandrillaris,Balamuthia mandrillaris,66527.0,,,INH,%,UO_0000187,,0.0
52960,52960,,,2659322,[],CHEMBL1026171,Antimicrobial activity against Balamuthia mandrillaris ATCC 50209 infected in HBMEC assessed as inhibition of amoeba-induced cytopathogenicity at 5 ug/mL after 24 hrs by LDH release assay,F,,,BAO_0000201,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151422,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,817752,=,1,1,=,,Inhibition,%,,16.0,CHEMBL614751,Balamuthia mandrillaris,Balamuthia mandrillaris,66527.0,,,INH,%,UO_0000187,,16.0
52961,52961,,,2659323,[],CHEMBL1026172,Antimicrobial activity against Balamuthia mandrillaris ATCC 50209 infected in HBMEC assessed as inhibition of amoeba-induced cytopathogenicity at 10 ug/mL after 24 hrs by LDH release assay,F,,,BAO_0000201,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151422,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://qudt.org/vocab/unit#Percent,817752,=,1,1,=,,Inhibition,%,,10.0,CHEMBL614751,Balamuthia mandrillaris,Balamuthia mandrillaris,66527.0,,,INH,%,UO_0000187,,10.0
52962,52962,,,2659538,[],CHEMBL1051483,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,16.0
52963,52963,,,2659539,[],CHEMBL1051473,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
52964,52964,,,2659540,[],CHEMBL1051468,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
52965,52965,,,2659541,[],CHEMBL1051460,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
52966,52966,,,2659542,[],CHEMBL1062983,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
52967,52967,,,2659543,[],CHEMBL1023504,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
52968,52968,,,2659544,[],CHEMBL1023494,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
52969,52969,,,2659545,[],CHEMBL1023488,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
52970,52970,,,2659546,[],CHEMBL1036288,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.008
52971,52971,,,2659547,[],CHEMBL1036283,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3274 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
52972,52972,,,2659548,[],CHEMBL1052242,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 37 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
52973,52973,,,2659549,[],CHEMBL1052246,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3413 by NCCLS M7-A7 method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
52974,52974,,,2659709,[],CHEMBL1051478,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 25 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
52975,52975,,,2659710,[],CHEMBL1051477,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 21 passages with gemifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
52976,52976,,,2659711,[],CHEMBL1051476,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 18 passages with levofloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
52977,52977,,,2659712,[],CHEMBL1051475,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3009 after 19 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
52978,52978,,,2659713,[],CHEMBL1051470,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
52979,52979,,,2659714,[],CHEMBL1051469,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1076 after 35 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
52980,52980,,,2659715,[],CHEMBL1051464,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 15 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
52981,52981,,,2659716,[],CHEMBL1051462,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 29 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
52982,52982,,,2659717,[],CHEMBL1051461,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1077 after 49 passages with clindamycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,8.0
52983,52983,,,2659718,[],CHEMBL1062986,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
52984,52984,,,2659719,[],CHEMBL1062985,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 26 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
52985,52985,,,2659720,[],CHEMBL1062984,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3665 after 38 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
52986,52986,,,2659721,[],CHEMBL1062979,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
52987,52987,,,2659722,[],CHEMBL1062978,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 44 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
52988,52988,,,2659723,[],CHEMBL1023505,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3676 after 50 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
52989,52989,,,2659724,[],CHEMBL1023498,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 29 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
52990,52990,,,2659725,[],CHEMBL1023497,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 33 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
52991,52991,,,2659726,[],CHEMBL1023496,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 41 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
52992,52992,,,2659727,[],CHEMBL1023495,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 3243 after 20 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
52993,52993,,,2659728,[],CHEMBL1023490,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 14 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
52994,52994,,,2659729,[],CHEMBL1052241,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 14 passages with clindamycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
52995,52995,,,2659730,[],CHEMBL1023489,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 1635 after 49 passages with clarithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
52996,52996,,,2659731,[],CHEMBL1023485,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 14 passages with Telithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
52997,52997,,,2659732,[],CHEMBL1023484,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 24 after 50 passages with moxifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
52998,52998,,,2659733,[],CHEMBL1036285,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 20 passages with azithromycin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.06
52999,52999,,,2659734,[],CHEMBL1036284,Antimicrobial activity against drug-resistant Streptococcus pneumoniae isolate 2527 after 14 passages with gemifloxacin measured after 10 antibiotic-free subculture by multi-step resistance selection technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1,,,CHEMBL1151428,Antimicrob Agents Chemother,2007.0,,CHEMBL1753,CLINDAMYCIN,CHEMBL1753,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,818243,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.016
